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Abstract
It is likely that the success of treatment techniques in increasing consumers’ sense of
inclusion in treatment decision making and increasing the likelihood for improved
treatment outcomes for individuals with severe and persistent mental illness depends on
the presence of common trait variables, such as empowerment and treatment-specific
efficacy and process variables, such as the therapeutic relationship and the use of a shared
decision-making style. To understand the relationships between these variables in
individuals with serious mental illness (SMI), this study used an archival data set
consisting of 396 adults with major depression and schizophrenia-spectrum disorders
from Philadelphia area community mental-health centers. Questions covered their
experience of global empowerment, the amount of confidence they had in asking
questions of their physicians, their sense of shared decision making, the quality of the
alliance with their treatment providers, and their perceived treatment
satisfaction/outcomes. Hierarchical regression and multiple linear regression analyses
were conducted to determine the relationship between the variables using the
Empowerment Scale (ES), Working Alliance Inventory (WAI), Perceived Efficacy in
Patient-Physician Interactions (PEPPI), Participatory Decision-Making Scale (PDMS),
and their contribution to perceived treatment outcomes in individuals with serious mental
illness, measured by the Mental Health Statistical Improvement Program Inventory
(MHSIP). Participants articulated greater treatment satisfaction outcomes in the presence
of greater perceived global empowerment, greater perceived inclusion in treatment
decision making, and greater perceived working alliance. Participants also articulated
greater sense of shared decision making in the presence of greater empowerment and
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working alliance. Treatment outcomes and sense of inclusion in decision making were
not significantly related to sense of treatment specific efficacy. The results of this study
indicate the need for greater understanding of how to increase the sense of empowerment
of individuals with SMI, as well as the need for clinicians to develop greater skill at
fostering a sense of inclusion and working alliance in treatment to ensure greater
treatment outcome satisfaction.
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Chapter 1: Introduction
Statement of the Problem
Today, individuals with serious mental illnesses (SMI) have the opportunity, more
than at any other time in the history of the treatment of mental illness, to participate in
and guide the direction of their care (Anthony, 1993). The clinicians who are providing
the treatment have a responsibility to allow these individuals to exercise this right for
inclusion and to begin to understand their role in helping consumers to do so (Warner,
2009). Therefore, clinicians must seek to empower consumers in their ability to become
active participants in their own treatment.
Consumers’ empowerment was first operationally defined by Rogers,
Chamberlin, Ellison, and Crean (1997). This group of researchers, who were considered
leaders in the self-help movement, was the first to apply the construct to individuals with
SMI. Their study suggested that programs should focus on increasing an individual’s
self-esteem and self-efficacy, increase perceived power particularly by increasing
financial resources, and decrease feelings of powerlessness in treatment (Rogers et al.,
1997). Current empowerment theory, research, and interventions suggest individual
well-being, along with the larger social and political environment, is a truer definition of
the construct because the construct includes a focus on mental health that requires both
mutual help from and the creation of a responsive community (Perkins & Zimmerman,
1995). Therefore, empowerment is best enhanced in an environment that seeks to
respond to individuals with SMI (SMI)1 needs by increasing their sense of control in their

1

SMI is defined differently by different researchers. For the purpose of this study, the sample included participants with the
following diagnostic criteria: Individuals with a primary Axis I diagnosis of schizophrenia, a schizophrenia spectrum disorder, or
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mental-health treatment. Mental-health professionals who strive to empower their clients
in their own mental-health care can be more confident that these individuals will be more
likely to adhere to treatment recommendations that are made on their behalf (O’Brien,
Fahmy, & Singh, 2009).
Similar to individuals with chronic health problems, such as diabetes or heart
disease, individuals with SMI are known to have poor adherence to treatment
recommendations, including medication regimens and attendance at appointments
(O’Brien et al., 2009). When these individuals fail to follow through with their scheduled
appointments, they may experience an increase in symptoms of their illness, which can
lead to a relapse, making more probable their need for treatment in the form of inpatient
hospitalization. This tendency to relapse represents a common spiral that ultimately
results in wasted resources, both because of the cost of the missed outpatient services and
the high expense of the inpatient hospitalization. Some researchers have suggested that
the current model of service provision is not conducive to improved client engagement in
treatment (Anthony, 1993; Chamberlin, 2009). Researchers and consumer advocates,
many of whom have been diagnosed with a mental illness themselves, have called for a
change from the traditional medical treatment model to a more consumer-oriented and
empowering model in an effort to improve engagement in the practices that will assist in
their recovery (O’Brien et al., 2009).
A large body of research exists that has investigated correlates of treatment
outcomes. The amount of perceived self-efficacy has been shown to be highly correlated

major depression. For all future references, this document will use the term SMI, but please note that for this study it only refers to
these three main diagnostic SMI subgroups. In a later section, the participants will be more thoroughly described.
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to an individual’s ability to recover from a mental illness (Maly, Frank, Marshall,
DiMatteo, & Reuben, 1998). The therapeutic alliance is another variable that has been
reliably linked to treatment outcomes (Lehman et al., 2004; O’Brien et al., 2009; Smerud
& Rosenfarb, 2008). That is, with greater reported working alliance, there are greater
reports of positive therapeutic outcomes (Smerud & Rosenfarb, 2008). The converse is
also true. In addition to therapeutic alliance, empowerment is increasingly becoming an
important focus in enhancing consumer efficacy (Perkins & Zimmerman, 1995; Smerud
& Rosenfarb, 2008). Changing the focus from problem-centered to patient-centered
interactions likely will result in a positive increase in reported therapeutic alliance, as will
the style that the clinician/physician uses in making treatment decisions. Determining the
relationships among these constructs and using this information to guide treatment
interventions will serve to improve treatment outcomes in general.
Purpose of the Study
This study attempted to uncover the relationships between consumer-reported
levels of empowerment and working alliance, and their reported perceived self-efficacy,
inclusion in treatment decision making, and treatment outcomes in the hopes of providing
direction and guidance to provider training and program direction. Moreover, this study
will further the current literature and understanding of the nature and value of assisting
consumers of mental-health services to engage actively in their mental-health treatment
and experience recovery from their diagnosed psychiatric disability.
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Relevancy of the Program Goals
This study addresses the program’s goal to produce practitioner-scholars who
have an appreciation and comprehension of the broad and general knowledge base that
informs the profession of psychology. In addition, this study addresses the program’s
goal of producing practitioner-scholars who are able to identify and understand issues of
individual and cultural diversity. Therapeutic alliance and empowerment are two
important concepts in the provision of mental-health services. They involve
understanding the need to be sensitive to multicultural issues, as well as being responsive
to, and gaining knowledge of, ethnically and racially different individuals. This study
accomplishes this goal by including a review of the literature that focuses on the
historical foundations of consumer empowerment, as well as on the current consumer
empowerment movement. Finally, this study serves as an endeavor to increase awareness
of the greater need for the evaluation of current therapeutic interventions, furthering the
advocacy efforts to change current policies for the provision of services for individuals
diagnosed with SMI.
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Chapter 2: Literature Review
The prevalence of mental illness in the United States is estimated to affect 26.2%
of Americans ages 18 years and older in a given year, according to a study that measured
the prevalence, severity, and comorbidity of mental illness in America (Kessler, Chiu,
Demler, & Walters, 2005). This statistic, when applied to the 2004 U. S. Census data,
suggests that a total of approximately 57.7 million individuals are diagnosed in a given
year with some type of mental health problem (DeNavas-Walt, Proctor, & Hill Lee,
2005). However, though mental disorders are somewhat common in the United States,
the greatest burden of mental illness belongs to those who are diagnosed with SMI
(Kessler et al., 2005). According to one study, SMI is associated with an annual loss of
earnings totaling $193.2 billion (Insel, 2008; Kessler et al., 2008). It is estimated that
only a small proportion, approximately 1 in 17, or 6%, of U. S. residents fall into this
more serious category (Kessler et al., 2005).
Changing Focus in Treatment
Treatment paradigms have shifted from a focus on diagnosing and treating the
mental illness to an ideology that seeks to assist individuals with mental disorders in
achieving their highest level of wellness (Chamberlin, 2009; Warner, 2009). This shift
has become a focal point in the development of new treatment approaches as more
individuals with SMI are able to regain levels of functioning they experienced prior to
their diagnosis. In fact, consumers with SMI have also been able to gain higher skill
levels post diagnosis (Chamberlin, 2009). One example of a diagnosis that falls under the
category of SMI is schizophrenia. Schizophrenia was once thought to be a lifelong and
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chronic prognosis. However, a study by Harding, Brooks, Ashikaga, Strauss, & Brier
(1987) suggested that there was the potential for different outcomes in the trajectory of
schizophrenia. The study followed 82 individuals with schizophrenia for 20 to 25 years
and indicated a great amount of heterogeneity in the functional outcomes of these
individuals. Specifically, the downward trajectory that was once thought inevitable by
treating clinicians was dispelled, as the study indicated that 73% of the participants led
moderate to very full lives (Harding et al., 1987). Furthermore, 81% of participants were
able to meet their basic daily needs, and 68% of the participants denied the presence of
symptoms or experienced only slight symptomatology (Harding et al., 1987).
The understanding that individuals with SMI can live fulfilling lives and have
greater input in their treatment planning has been a starting point for the consumer
movement in America, a type of grass roots effort led by individuals diagnosed with
psychiatric disabilities. This movement began to form in early 1970, during a time when
important decisions about funding and provision of mental-health care were being
decided by state and federal legislators. Former consumers of mental-health treatment
services across the nation began to gather together with the goal of developing a greater
awareness of patients’ rights and their inclusion and influence in treatment planning. The
continued focus of these groups today is to bring attention to the lack of inclusion of the
individual in the actual treatment decision-making process (Warner, 2009).
The World Health Organization (WHO) suggested that the focus of change should
be on mental health, rather than on mental illness. Mental health is defined as a state of
complete mental, physical, and social well-being (World Health Organization [WHO],
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2005). In this definition, the focus is not only on targeting and eradicating the symptoms,
but also on improving individuals’ life experiences (WHO, 2005).
However, the statistics discussed at the opening of this chapter indicate that SMI
remains a significant public-health problem and that treatment providers are still in the
beginning stages of understanding all the factors that contribute to individuals’
recoveries. Therefore, the question remains: How do individuals diagnosed with SMI get
better, and what variables are important in fostering individuals’ desires and abilities to
recover from their mental illnesses? This chapter will review the current understanding of
the impact that the constructs of self-efficacy, empowerment, therapeutic alliance, and
inclusion in treatment decision making have on individuals diagnosed with SMI under the
larger umbrella of the mental-health transformation that is occurring across the nation. A
brief history of the changing treatment models will be reviewed in order to better
understand how and why the provision of healthcare is changing. Next will be a review
of the four previously mentioned constructs that are gaining greater attention in the field
as being related to focus of the transformation – namely, recovery from mental illness.
Self-efficacy, an important construct of human agency and motivation, is reviewed in this
context. Following that will be a discussion of empowerment as a construct, a historical
movement, and as a catalyst for mental-health recovery. After the review of
empowerment, the concept of therapeutic alliance and its role in recovery from diagnosed
psychiatric disability will be reviewed and discussed. Finally, information about the
importance of physician’s inclusion of the client in decision making, in relationship to
recovery from mental illness, is discussed. Some of these constructs have been studied at
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length and have a large body of support in the literature. This study seeks to bring these
constructs together in order to determine their contribution to the process of recovery in
individuals with SMI.
History of Changing Treatment Models
Medical Model Versus Patient-Centered Care
In the process of determining the best treatment for individuals with SMI,
treatment approaches have progressed from using a medical or biological model to taking
an approach that looks at the whole person and, furthermore, encourages the inclusion of
the individual in his or her treatment. The medical model has been rooted traditionally in
the belief that the physician holds the knowledge and power in the relationship to make
all of the treatment decisions for the individual seeking the treatment. This approach to
treatment largely continues to govern the order and timing of treatment in the behavioralhealth field today (Brown, Rempfer, & Hamera, 2008). However, a growing consensus
of consumers, consumer advocates, researchers, and clinicians considers the use of
recovery-oriented and patient-centered approaches to individuals with SMI to be more
effective (Brown et al., 2008). Trinh, Moore, and Brendel (2008) proposed that the
primary issue at the core of the traditional medical model is a debate about respecting
clients’ autonomy versus achieving the best positive clinical results. This achievement
requires consideration of inclusion of individuals’ opinions and preferences in their care.
According to Trinh et al. (2008), this construct can be conceptualized as physician
“beneficence” (Trinh et al., 2008). Understanding a patient’s right to autonomy also
requires respecting the right of an individual to refuse or choose a particular course of
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treatment (Trinh et al., 2008). It furthermore entails the individual’s right to lifestyle and
treatment choices, given that he or she is able to give informed consent, can consider the
options rationally, and can make consistent choices over time (Trinh et al., 2008).
Caveats are put into place to ensure that, though there is respect for what might be a
“poor” choice for a client, the treatment team can and should intervene to ensure that
clients do no harm to him or herself or to others. Thus, in the patient-centered model of
care, the focus is on allowing the individual to increase his or her independence in choice
of treatment planning. Consumers of behavioral-health services are furthermore
encouraged to be active participants in their treatment. Many of the defining components
of patient-centered care were also emphasized in the significant paradigm shift that has
occurred in the behavioral-health service field. Called the mental-health system
transformation, the behavioral-health field has received considerable attention from
consumers, advocates, and subsequently governing agencies calling for the drastic change
and improvement in the delivery of services. The following section reviews the recent
changes to the behavioral-health system.
The Transformation of the Mental-Health System
In 2001, President George W. Bush announced the development of the New
Freedom Initiative (NFI) as a means to promote awareness of and increase access to
employment and educational opportunities for individuals with disabilities (New
Freedom Commission on Mental Health [NFCMH], 2003a). The NFI was also designed
to increase access to community resources and other technologies for the purpose of
assisting individuals’ full access to community life. In other words, services were to be
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established for individuals with disabilities that would allow for greater community
integration (NFCMH, 2003a). The development of the NFI was in part related to the
1999 ruling in the Olmstead v. L.C. decision in which the Justices of the United States
Supreme Court ruled, in line with the Americans with Disabilities Act, under Title II, that
individuals with mental disabilities have the right to live in and receive treatment in the
greater community instead of in institutional settings. The landmark ruling also indicated
that the community had a responsibility to develop resources for individuals with
disabilities to ensure their successful adaptation and ability to thrive in their communities
(NFCMH, 2003a).
The findings from the NFI resulted in the development of the New Freedom
Commission on Mental Health (NFCMH) in 2002. The charge of the NFCMH was to
study the mental-health service delivery system in the United States for the purpose of
making recommendations that would enable adults with SMI and children with serious
emotional disturbances to be integrated with their communities. In July of 2003, the NFC
submitted the final report of the findings in their document entitled, Achieving the
Promise: Transforming Mental Health Care in America (NFCMH, 2003b). After a year
of reviewing research and testimony, the NFC found that recovery from mental illness
was a real possibility. Under the guidelines for a transformed system, the NFCMH
advised that recovery from mental illness was to be the goal of all treatment that is
provided to individuals seeking treatment (NFCMH, 2003b).
The NFCMH provided the following definition of recovery from mental illnesses:
“Recovery refers to the process in which people are able to live, work, learn, and
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participate fully in their communities” (NFCMH, 2003b, p. 7). Therefore, according to
this definition, for some individuals recovery will include living a fulfilling life in the
presence of a disability. For others, recovery will also include either a reduction or a
remission of all symptoms. By viewing recovery in this manner, hope for a meaningful
life is increased. Research has shown that hope is integral in an individual’s ability to
recover (NFCMH, 2003a).
The NFCMH noted, however, that system change was needed in order to combat
the reality of a fragmented and disconnected mental health treatment delivery system.
According to the Commission report, “In a transformed system, consumers and family
members will have access to timely and accurate information that promotes learning,
self-monitoring, and accountability” (NFCMH, 2003a, p. 8). Personalized care is a part of
this guideline and is loosely defined as choosing which treatment providers will be on the
consumer’s team, what the modality of treatment will be, and how appropriate healthcare
will be provided. Additionally, the report outlined a plan of action for individuals when
first diagnosed with SMI. According to the Commission, healthcare providers are
charged with the duty of “develop[ing] an individualized plan of care for managing the
illness” by collaborating with the consumer and with his or her families (NFCMH, 2003a,
p. 8). The NFCMH advised that the provision of all healthcare will include shared
decision making and consumers collaborating in the treatment plan.
The NFCMH indicated that three primary obstacles prevent individuals with
psychiatric disabilities from receiving the care that they deserve. These included “the
stigma that surrounds mental illnesses, unfair treatment limitations and financial
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requirements placed on mental health benefits in private health insurance, and the
fragmented mental health service delivery system” (NFCMH, 2003b, p. 1). Based on
these observed obstacles, one goal of the transformation of the mental-health system,
therefore, is to reduce the stigma surrounding mental illness. By making recovery the
primary goal and outcome of mental-health treatment, the hope is that stigma will be
reduced, reinforcing the hope of recovery for every person diagnosed with a mental
illness. The desired outcome of the transformation, according to the NFCMH, will allow
for American consumers to seek mental healthcare when they need it, as the stigma
surrounding mental illness and the need for treatment will be reduced or eliminated.
In the 2002 report from the NFCMH, the onus of the responsibility for the
observed deficits in the behavioral-health delivery system were not attributed solely to a
lack of professionalism or compassion in the behavioral healthcare workers. Instead, the
NFCMH suggested that the problems in the delivery of services were primarily caused by
the lack of available effective and efficient community services on which people with
SMI can count. The suggestion was that the programs that were evaluated and found to
be fragmented across levels of government and within many agencies needed to be
retooled and better integrated into the community in order to provide the most effective
treatment (NFCMH, 2003a). However, while there is a dearth of adequate community
resources that are targeted to ensure successful recovery for individuals with SMI, one
can argue that the treatment providers who are making referrals to the available
community resources lack the skills needed to build healthy working alliances with
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individuals with SMI, thereby increasing their sense of hopelessness in their ability to
recover.
According to the NFCMH, two principles are involved in successfully
transforming the delivery of behavioral-health services: (a) services and treatment must
be consumer and family centered, and (b) treatment must focus not only on managing
symptoms, but also on increasing the consumers’ ability to cope with the challenges of
life, on facilitating recovery, and on building resilience (NFCMH, 2003a/b). These
principles reflect the need for treatment providers to consider the consequences of
interactions with people with psychiatric disabilities, as providers may, in fact, be
hindering their clients’ ability to recover.
Substance Abuse & Mental Health Services Administration (SAMHSA) and
Recovery
In addition to the two previously mentioned guiding principles of a transformed
mental health system, SAMHSA released the Federal Mental Health Action Agenda in
2009, in which the President’s Executive Order 13263 of April 2002 listed five principles
around which the NFCMH framed its work (SAMHSA, 2009; United States Department
of Health and Human Services [UHHS], 2002). The principles were designed to
exemplify the overarching vision that is to shape the necessary work to change the system
of behavioral healthcare. The five principles include (a) The focus of the desired
treatment outcomes will be to seek to attain each individual’s maximum level of
recovery, as defined by the NFCMH (i.e., highest levels of employment, self-care,
interpersonal relationships, and community integration); (b) All health and human service

CORRELATES OF & CONTRIBUTIONS TO TREATMENT OUTCOMES

14

providers, as well as both the public and private funding sources, will effectively manage
and coordinate the needed behavioral- health treatment and delivery of services on a
community level; (c) Behavioral healthcare will focus on ensuring that policies will
maximize the usefulness of existing resources by increasing cost effectiveness and
reducing unnecessary and burdensome regulatory barriers; (d) Research findings will be
reviewed regularly for the purpose of determining how to most effectively influence the
delivery of services; and, (e) The NFCMH will ensure that their recommendations will
promote innovation, flexibility, and accountability at all levels of governing agencies
while respecting the constitutional role of the States and Indian tribes (NFCMH,
2003a/b). Clearly, transformation of this magnitude will require the restructuring of all
behavioral-health delivery systems. Additionally, the current and incoming behavioralhealth care workforce will require retraining in recovery-oriented principles in order to
attain the goals established by the NFCMH and SAMHSA.
The NFCMH set forth six similar goals to aspire to in order to transform the
mental-health treatment delivery system. The transformation requires developing a
behavioral healthcare system in which Americans understand that: (a) mental health is
essential to overall health; (b) mental healthcare is consumer and family driven; (c)
disparities in mental-health services are eliminated; (d) early mental-health screening,
assessment, and referral to services are common practice; (e) excellent mental healthcare
is delivered and research is accelerated; and (f) technology is used to access mental
healthcare and information. In particular, the fifth listed goal suggests the need for
further training of clinicians and physicians providing treatment to individuals with
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psychiatric disability. Training will need to include a strong focus on using treatment
approaches that have demonstrated effectiveness through empirical testing.
Based on the requisite changes that will need to be made to transform the
provision of behavioral health treatment to be compliant with the recommended best
practices for the delivery of treatment, it is important to conceptualize the constructs that
correlate with an individual’s ability to recover. The following sections discuss four
correlates that appear to be highly important in the provision of treatment, and thus may
make an individual with SMI more likely to maintain the focus and motivation required
to gain and maintain recovery from the diagnosed psychiatric disability. These constructs
include self-efficacy, global empowerment, therapeutic alliance, and the physician’s use
of a shared decision-making style.
Self-Efficacy
Self-Efficacy and Behavior
Social cognitive theory explains human functioning through an interaction of
reciprocal determinism (Bandura, 1986). Individuals’ behaviors both influence and are
influenced by their environments and by personal factors (Bandura, 1977; 1986). Social
Cognitive Theory involves an understanding of the feed-forward system of selfregulation. This system differs from other theories of behavioral control that are rooted
in a negative feedback system, which merely attempts to prevent error (Bandura, 1986;
Bandura & Locke, 2003). Self-efficacy beliefs influence this system and are central to
individuals’ successful completion of a behavior or goal, because self-efficacy beliefs
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affect how individuals think, feel, behave, and motivate themselves (Bandura, 1986;
2004).
When considering the importance of self-efficacy and individuals with SMI, one
can clearly see that individuals’ perceptions of their own abilities and their environmental
conditions play a significant role in the way these individuals manage their mental illness.
Therefore, when considering recovery from SMI, perhaps nothing is more essential to
acting in ways that will positively affect their experience of mental illness than the belief
in their capabilities to do so. In order to better understand how this construct impacts the
management of a mental illness, the following section reviews the definition of selfefficacy. Then, the effect of self-efficacy on specific healthcare behaviors is discussed.
Definition of Self-Efficacy
Bandura (1994) defined self-efficacy as peoples’ beliefs about their capability to
enact a certain behavior. People must believe that they can produce expected levels of
performance that influence the events that affect their lives, suggesting a positive
relationship between individuals’ self-efficacy and their beliefs about their ability to cope
in a given situation (Bandura, 1994). Moreover, beliefs about self-efficacy affect how
individuals think, feel, behave, and even motivate themselves in a given situation
(Bandura, 1994). Self-efficacy, then, is regarded as context- and task-specific in relation
to a particular behavioral outcome (McCann, Clark, & Lu, 2008). Self-efficacy is
different from self-esteem, as the latter is considered to be a generalized sense of selfworth (McCann et al., 2008). Owing to its behavior-specific nature, self-esteem can be
learned and enhanced upon through increasing attempts to complete goals and tasks
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(Lorig & Holman, 1993). It is not a personality trait that remains relatively stable
throughout the lifespan, like self-efficacy (Lorig & Holman, 1993; McCann et al., 2008).
According to Bandura (1997), among the different mechanisms of human agency,
a sense of personal efficacy is more central to one’s belief in the ability to exercise
control over the events that affect one’s life. Furthermore, he stated that regardless of
any other factors that serve as guides and motivators for behavior, all are rooted in the
core belief of one’s ability to achieve the desired effect by acting, or actually taking
action, to meet a goal (Bandura, 1997; Benight & Bandura, 2004). When this core
element is not present, an individual has little incentive either to act or to persevere when
tasks become difficult. With taxing pursuits, individuals must judge their efficacy as
sufficient both to sustain their motivation and task-oriented focus and to effectively
manage any distressing emotional states and self-destructive thought patterns that may
surface while seeking to meet their goal (Bandura & Locke, 2003). These debilitating
beliefs can impair the individual’s ability to execute the necessary activities related to the
goal. Beliefs in one’s ability to act in a way that will mitigate the experience of SMI will
also affect the outcome of treatment. The following section reviews the impact of selfefficacy on motivation to manage illness and actual treatment outcomes.
Self-Efficacy and Motivation for Healthcare Behaviors
Bandura (1986) believed that beliefs in personal self-efficacy are the actual
foundation of human agency. He suggested that individuals are more likely to follow
through on important healthcare behaviors if two overarching circumstances exist
(Bandura, 1986; Moore, 1990). First, individuals’ health beliefs must indicate that a
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specific behavior will produce and result in the desired outcome (Moore, 1990). For
example, medication adherence in the population diagnosed with SMI is currently at
50%, with a success rate for decreasing targeted symptoms estimated to be in a range
from 5 to 25% (Corrigan, Liberman, & Engel, 1990; Lacro, Dunn, Dolder, Leckband, &
Jeste, 2002; Warner, 2004). In this example, the medications are not producing the
desired or expected outcome. Therefore, individuals may choose not to take the
medication, as their expectation may be that the medication should be able to take away
all of their symptoms. Individuals are even more likely to stop taking their medications if
they are also experiencing side effects from the treatment (Corrigan et al., 1990).
The second condition that needs to be present in order to increase the likelihood
that individuals will follow through on important healthcare behaviors is confidence in
their ability to actually carry out a particular behavior or action sequence to achieve the
desired and intended result (Moore, 1990). These tasks could include scheduling and
attending doctors’ appointments, remembering to drop off prescriptions for medications
that are needed for their physical and mental health, and picking up medications from
their pharmacies, to name only a few. Each of these tasks requires a number of
successive behaviors in order to be completed. Individuals with SMI who have strong
perceived self-efficacy are better able to address the many and oftentimes complex tasks
that are required to maintain their physical and mental wellness (Corrigan et al., 1990;
Lacro et al., 2002; Moore, 1990).
It is not surprising, then, that individuals who do not feel capable of completing a
task are not likely to attempt it. They are also less likely to persevere in their efforts to
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achieve the goal of the task. With this in mind, one can understand that treatment
outcomes are also impacted by the presence or deficiency of self-efficacy. The following
section reiterates the importance of self-efficacy on the outcome of treatment for
individuals with medical and mental-health disorders.
Self-Efficacy and Treatment Outcomes
Studies of self-efficacy have found this construct to be a powerful mediator of
health behaviors and outcomes across many patient populations and health conditions
(Aljasem, Peyrot, Wissow, & Rubin, 2001; Franks, Chapman, Duberstein, & Jerant,
2009). Regarding healthcare outcomes, correlation between self-efficacy and
individuals’ beliefs that they are able and capable of performing at a level that will
produce positive effects in their health has been found (McCann et al., 2008).
Furthermore, studies have shown that peer-led interventions increase and strengthen selfefficacy and result in positive changes in health behaviors and outcomes in individuals
with chronic conditions (Warnecke, Morera, Turner, Mermelstein, Johnson, & Parson, et
al., 2001). However, few studies have reviewed longer term effects of these programs.
Therefore, the effect of peer-led intervention programs on illness management selfefficacy remains unclear (Franks et al., 2009).
Lorig et al. (1999) developed the most widely used and researched health care
intervention known to enhance self-efficacy, known as the Chronic Disease Self
Management Program (CDSMP). This program provides participants with self-efficacy
and skills training that is required to manage their chronic medical conditions, regardless
of the diagnosis. The intervention seeks to enhance self-efficacy through mastering six
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core self-management tasks. The tasks include solving problems, making decisions,
using resources, forming a positive relationship with the provider, making an action plan
for health behavior change, and tailoring treatments to individual requests (Lorig et al.,
1999). The CDSMP used highly trained nonhealthcare providers, or participants’ peers,
to deliver the intervention. The results of a study designed to measure the program’s
efficacy, when considering personality as a moderator variable, showed significant
improvement in illness management self-efficacy for individuals with SMI (Franks et al.,
2009). At a practical level, understanding the treatment moderators of self-efficacy can
help providers of healthcare increase the efficacy of treatment interventions by
identifying potential candidates for whom the intervention is likely to be most effective
(Franks et al., 2009). The present study sought to increase the current understanding of
the correlates of healthcare self-efficacy in a population of individuals with SMI, an area
that was previously underrepresented in the literature.
Self-Efficacy Among Individuals with Serious Mental Illness
The role of self-efficacy is an important consideration in coping with chronic
conditions. Carpinello, Knight, Markowitz, and Pease (2000) suggested that self-efficacy
for recovery from mental illness may be conceptualized as belief in one’s ability to
overcome the adversities that are associated with mental illness. Self-efficacy affects the
amount of effort that an individual puts into coping with the disease and the tendency
toward maintaining perseverance in coping (Raggi, Leonardi, Mantegazza, Casale, &
Fioravanti, 2009). Individuals with SMI may internalize the experience of stigma that is
associated with having a mental illness (Watson, Corrigan, Larson, & Sells, 2007). As a
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result, they may begin to experience diminished self-efficacy and self-esteem (Watson et
al., 2007). However, not all individuals who have a mental illness experience a loss of
their ability to manage their daily lives. Some individuals respond to the damaging
effects of stigma by increasing their determination and drive, becoming energized and
even empowered in their attempts to maintain wellness (Watson et al., 2007). Having a
high sense of self-confidence in one’s own ability to act in a way that will help to control
symptoms of psychiatric disability has been found to have health-enhancing effects in
itself (Marks, Allegrante, & Lorig, 2005; Raggi et al., 2009). High self-efficacy has also
been identified as a primary mechanism associated with recovery from mental disorders
(Anthony, 1993; Coursey, Farrell, & Zahniser, 1991; Davidson & Strauss, 1992;
Rosenfield, 1987; Shaffer & Gambino, 1978).
However, a percentage of individuals with SMI tend to remain relatively
withdrawn. They may appear to be indifferent to the reality of needing to make efforts to
take an active role in their self-care (Raggi et al., 2009). Research has suggested that
prior to being labeled as a person with a mental illness, people have already internalized
stereotypes about the meaning of having a mental illness (Link, 1987; Link, Cullen,
Struening, Shrout, Dohrenwend, 1989). Therefore, having low self-efficacy may mediate
the change in disease self-management behaviors, resulting in negative physical and
mental-health outcomes (Marks et al., 2005).
When one faces the reality of the onset of a mental illness, the stereotypes that
were previously formed become relevant to oneself. Some might perceive this event as a
stigmatizing experience and fear that rejection from their social networks and
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communities is inevitable. Rejection, and the thought of potential rejection, can lead to
isolation, the possibility of job loss, eventual lowered income, and the gradual reduction
of ability to function in the community (Watson et al., 2007). Depending on the amount
of perceived self-efficacy prior to the onset of a diagnosis of SMI, this negative sequence
may be avoidable. Therefore, it is important to determine the mechanisms that can
impact an individual’s sense of self-efficacy to manage the daily tasks of life and his or
her illness in order to improve outcomes.
Self-Efficacy as an Important Variable in Recovery from Illness
Self-efficacy has been found to be an important variable in recovery from
physical illnesses. One study found that limited knowledge and self-efficacy regarding
active self-management of one’s physical health was a primary barrier to the attempts of
those with SMIs to engage in health-promoting behaviors (Schmutte et al., 2009). In
addition, results from the study indicated that despite expressed interest in learning more
about health promotion, most of the study’s participants indicated a sense of personal
futility and powerlessness in their ability to improve their physical health. Furthermore,
results from the study suggested that any effort to improve the physical wellness of
individuals with SMI must address self-efficacy as a foundation for improving their selfcare for their health needs. If self-efficacy is an important factor in recovery from
physical health issues, it is logical to assume that issues of self-efficacy would be
important in the recovery from psychiatric disability. Individuals with SMI must feel
able to enact the changes that are required to attend to the behaviors that will help them to
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recover, such as asking treatment-related questions about medications, investigating other
treatment alternatives, and actually following through with recommended treatment.
Self-efficacy has also been found to be a significant variable in recovery from
psychiatric disabilities. In a study that examined the relationship between participation in
consumer-run services and recovery of social functioning in individuals diagnosed with
SMI, researchers found that behavioral health services that focus on helping people learn
how to cope effectively with their symptoms help consumers to become more hopeful
and to develop a greater sense of self-efficacy, which, in turn, may increase their
likelihood of having a positive outcome (Yanos, Primavera, & Knight, 2001). The study
results also suggested that there are two separate paths to recovery from mental illness.
One suggested path may be taken by individuals who already have a high sense of selfefficacy and who feel more confident because their symptoms are more effectively
managed by medication (Yanos et al., 2001). These individuals may, therefore, have less
of a need to cope in an active manner (Yanos et al., 2001). The other path to recovery
suggested by Yanos et al. (2001) may be taken by people who tend to cope more actively
while experiencing more symptoms, as these individuals may feel less sure in their ability
to manage symptoms, though they may still work more actively to manage them.
Regardless of the pathway taken, self-efficacy plays an important role in recovery from
mental illness.
Based on a brief review of the literature that indicates the importance of
individuals with SMI having a sense of their ability to effectively impact their own lives
through the management of their mental illness, one can easily appreciate the importance
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of assisting these individuals with enhancing their sense of self-efficacy. Through the
lens of social cognitive theory, individuals have vast potentiality that can be developed
through direct and vicarious experiences. The ability to develop a strong sense of selfefficacy is still limited, however. The following section introduces the concept of
empowerment and its impact on the individual with SMI. The history of the
empowerment movement is first discussed in order to better understand the catalyzing
effects of this important construct.
Empowerment
History of Empowerment
Empowerment is a concept that is historically rooted in the consumer movement,
which began with the advent of the professional rehabilitation services and initiatives that
were present in the 1970s (Chamberlin, 2009; Chamberlin, Rogers, & Ellison, 1996;
Warner, 2009). With this movement, the focus shifted from a medical, perhaps more
paternal, model for treatment towards a consumer-centered focus (Chamberlin, 2009).
Similarly, the concept of empowerment has gained the momentum of a social movement
and has led to important changes in the way that behavioral healthcare is delivered
(Shean, Bell, & Cameron, 2007). The restructuring of the provision of treatment for
individuals with SMI has been an empowering change for recipients of the treatment.
This paradigm shift has created an environment for individuals to become actively
involved in making decisions about their treatment (Warner, 2009). This evolving model
also engenders the advocacy efforts of individuals with SMI for the development of
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accessible recovery-oriented services that will enhance the positive culture of sustained
remission from their symptoms (Warner, 2009).
Empowerment is an important concept in what is being labeled the recovery
model for mental illness (Shean et al., 2007). The model recognizes the importance of
the subjective feelings of wellness, such as healing, hope, and empowerment. It also puts
emphasis on the importance of interpersonal support networks consisting of peers with
mental illness who have been able to regain a sense of wellness and productivity in their
lives (Warner, 2009). Finally, the recovery model includes the significant role that these
individuals’ service providers and other healthcare workers play in their return to more
balanced, healthy, and productive lives (Shean et al., 2007; Warner, 2009). Since the
beginning of the movement, activists for change in the provision of mental-health
services have emphasized the need to empower individuals, to collaborate with them in
treatment decision making, and to stress that all individuals are entitled to basic human
rights (Warner, 2009).
The change in treatment philosophy from a medical-based model to a consumercentered and recovery-oriented model, has resulted in several key principles that are
considered central to the recovery of an individual with a psychiatric disability. First, a
renewed understanding and desire for the eradication of stigma that has been attached to
having a mental illness has been a central focus of the movement. Attempts to eliminate
the stigma of mental illness have included factors such as changing the language
surrounding treatment and treatment-oriented care. Second, the importance of providing
education to the consumers of behavioral-health treatment about managing their illness in
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order to increase understanding and empowerment has grown. Third, the creation of
peer-run services, mentoring, and other support mechanisms, such as drop-in centers that
encourage wellness through advocacy, have increased (Warner, 2009). These service
priorities are grounded in understanding the importance of considering all individuals as
able to recover from the debilitating effects of psychiatric disability.
With the advent of the consumer movement and the focus on empowerment,
clinicians who operate within traditional treatment frameworks have been educated to
consider that their clients with SMI might be able to work, enjoy social relationships, and
develop a support network through community involvement and inclusion (Warner,
2009). In addition, mental-health professionals have become aware of the active efforts
of individuals with SMI to advocate for change in the provision of behavioral-health
services. Individuals recovering from a mental illness have successfully advocated to
change legislation and program models and have started to change the perception of
individuals with SMI.
A growing body of data and research emphasizes the importance of empowerment
in recovery from mental illness (Chamberlin, 2009; Warner, 2009). It supports the notion
that recovery and recovery-oriented care, including the development of services that are
focused on increasing self-efficacy and reducing the experience of internalized stigma,
are valuable in empowering individuals with SMI, thus improving their long-term
prognostic outcome (Warner, 2009). Furthermore, a substantial proportion of individuals
with SMI actually fully recover from their illness. Moreover, even more individuals are
projected to regain a good level of social functioning (Warner, 2009).
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In order to better understand the construct of empowerment, one must define it.
The remainder of this section is dedicated to discussion about the development of the
definition of empowerment, the current methods used to measure this construct, the
importance of empowerment in recovery from mental illness, and the factors related to
individuals’ experiences of empowerment.
Definition of Empowerment
Many definitions for the term empowerment are used to conceptualize a currently
poorly delineated construct. However, they all imply that empowerment includes more
than the traditional psychological concepts of self-esteem, self-efficacy, competency, and
internal versus external locus of control (Perkins & Zimmerman, 1995). In general, the
definitions are consistent in comparing empowerment to the intentional ongoing process
centered in the local community, involving mutual respect, critical self-reflection, caring,
and group participation. Through this ongoing process, individuals who are found to be
lacking an equal share of valued resources gain greater access to and control over the
resources that are available (Cornell Empowerment Group, 1989). More simply stated,
empowerment is the process by which people gain control over their lives, participate in
their communities, and gain a critical understanding of their environment (Zimmerman,
Israel, Schulz, & Checkoway, 1992). Chamberlin (2009) suggested that the critical
elements of empowerment include access to information, inclusion in decision making,
assertiveness, and self-esteem. Perhaps most interesting is the agreement that
empowerment is both an individual and a group phenomenon, such that individuals are
inspired by groups that are focused on these domains (Chamberlin, 2009). Perkins and
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Zimmerman (1995) suggested that empowerment includes the importance of interacting
with others to achieve goals, and to gain access to resources and of the need for some
level of critical understanding of the sociopolitical processes responsible for the
development of treatment guidelines for individuals with psychiatric disability. This
definition of empowerment introduces new implications for the current model of
psychiatric rehabilitation programs, such as allowing once disenfranchised groups, like
individuals with SMI, to develop the programming in collaboration with mental-health
professionals, or without the input of clinicians entirely (Chamberlin, 2009).
Additionally, theories of empowerment also include processes and outcomes. The
presence of processes and outcomes suggests that actions, activities, or structures may be
considered empowering (Anthony, 1993; Chamberlin, 2009). Thus, at the organizational
level, these processes can be construed as collective decision making and shared
leadership (Perkins & Zimmerman, 1995). At the community level, processes might
include collective action to access government and other community resources.
Outcomes would refer to operationalizations of empowerment that allow for the study of
the consequences of empowering processes (Perkins & Zimmerman, 1995).
Clearly empowerment has become a critical construct of focus for understanding
the development of individuals, organizations, and communities (Chamberlin, 2009;
Perkins & Zimmerman, 1995; Rogers et al., 1997; Zimmerman et al., 1992). In the last
10 to 15 years, it has developed into a paradigm-challenging construct and is now highly
popular in the discipline of psychology and many other fields (Kuhn, 1970; Perkins &
Zimmerman, 1995). The field of psychology also must investigate the relationship
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empowerment has with other core constructs in treatment. To address this question, one
first needs to select the level of empowerment to be investigated.
As previously discussed, empowerment occurs at several levels of an individual’s
life experience. It includes the processes by which people gain control over their lives,
participate in their communities, and develop a critical understanding of their surrounding
environments. For the purposes of this study, empowerment will be measured at the level
of the individual, not the larger societal or community level. Specifically, the
relationship between the provider and the consumer, a relationship representative of one
societal structure that might be indicative of how empowered a person might feel in his or
her daily life, will be investigated.
Empowerment and Recovery from Psychiatric Disability
In order to begin to understand the importance of empowerment to the consumer
movement, one must consider that individuals who are diagnosed with a SMI may feel
disempowered (Warner, 2009). This sense of disempowerment may stem from
experiences with involuntary treatment, including involuntary inpatient commitments, the
persistent paternalistic approach that is so pervasive in current traditional outpatient and
inpatient treatments, the ongoing societal stigma regarding individuals with mental
illnesses, and even the stigma that individuals with psychiatric disabilities may attach to
themselves, independent of beliefs or attitudes others may harbor towards them (Warner,
Taylor, Powers, & Hyman, 1989). Studies have even suggested that individuals may feel
the need to conform to an image of incapacitation and worthlessness, or otherwise
embody the sick role (Warner, 2009). Of importance, this sense of disempowerment may
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also be a manifest symptom of SMI. For example, individuals experiencing anhedonia
may also tend to perceive they are lacking in ability to achieve at a task. The problem
arises when failure to attempt a task becomes a perpetual cycle, as this may result in
individuals with SMI believing that they are ultimately dependent on their treatment
providers or that they are unable to gain control over psychiatric disability (Warner,
2009). Reducing the level of stigma individuals experience and label themselves with
may ultimately increase their sense of empowerment and eventual functioning. Having a
sense of empowerment is important in the recovery in individuals with schizophrenia and
other SMI. Empowerment challenges the pessimistic view of a diagnosis of SMI and
other psychiatric disabilities as chronic and deteriorating (Brown et al., 2008).
Research has been conducted to examine constructs, such as quality of life and
self-esteem, in an effort to understand the correlates of mental illness and the factors that
influence the efficacy of treatment (Brekke, Levin, Wolkon, Sobel, & Slade, 1993;
Resnick, Rosenheck, & Lehman, 2004). Interestingly, the older, more medically based
model’s definition of recovery from mental illness remains vital to the construct of
empowerment, in that the individual who has recovered has maintained a level of
remission of their mental illness such that there is no trace of the illness (Resnick et al.,
2004). Indeed, if a person is no longer experiencing major symptoms of his or her mental
illness, the consumer would understandably feel empowered and able to seek to
reintegrate into his or her community.
A recent definition for recovery suggests that another characterization of the
construct encompasses the individual’s attitude toward life, or a life orientation (Resnick,
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Fontana, Lehman, & Rosenheck, 2005; Warner, 2009). This definition suggests the
importance of tailoring treatment so that individuals seeking mental healthcare are able to
experience a sense of empowerment through change in attitude toward life. This
treatment tailoring is thought to be the key motivating factor in a patient’s perceived and
actual treatment outcome (Warner, 2009). In addition, the idea that an individual is able
to mend from the effects of the mental illness on his or her life, such as the loss of
employment, relationships, and stable housing, suggests the likelihood that the individual
will be able to develop a greater sense of self-efficacy. Furthermore, tailoring treatment
to meet the individual’s needs is, in its very essence, empowering the individual to
achieve a level of meaning, regardless of current experience with mental illness. Such an
approach to treatment is likely to result in increased life satisfaction and quality of life.
Therefore, in a person-centered model in which individuals are supported in their
attempts to regain a level of integration with their community that meets their needs and
creates a sense of meaning, regardless of whether or not they are still experiencing
symptoms of a mental illness, is understandably vital to the recovery of the individual.
Empowerment and Self-Efficacy
The construct of self-efficacy has been linked to better treatment outcomes for
individuals with SMI (Raggi et al., 2009). It is also considered an important factor in
empowering individuals. Self-efficacy, as previously defined, is one’s belief in the ability
to enact a specific behavior (Bandura, 1977). The presence of self-efficacy is necessary
when dealing with a chronic illness because it can impact the effort, perseverance,
resilience, and adherence to treatment (Raggi et al., 2009). These factors are all
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significant in the successful management of a chronic disease. Therefore, having a high
sense of confidence in one’s ability to perform the behaviors that are needed to control
symptoms may be considered health enhancing by itself. Low self-efficacy may mediate
change in illness self-management behaviors and therefore worsen mental- and physicalhealth outcomes (Marks et al., 2005). When given the chance to express their own
desires for course of treatment, one can understand that individuals will feel more control
over their lives. This sense of control is considered to be an important factor in the
individual’s ability to maintain mental health and even to recover from mental illness
(Chamberlin, 2009). According to Cattaneo and Chapman (2010), the process of
becoming empowered is successful only when a personally meaningful increase in power
is obtained through a person’s own efforts, which requires the interplay of self-efficacy,
agency, self-regulation, and self-determination. When considering SMI, the importance
of self-efficacy is evident. If empowerment is, in fact, mediated by self-efficacy, and
individuals report greater amounts of perceived self-efficacy, then greater amounts of
empowerment should be present, as well.
Empowerment and Adherence to Treatment
A central theme in the treatment of individuals with SMI is the question dealing
with the necessity and importance of empowerment in order to achieve good treatment
outcomes (Warner, 2009). Studies have found a correlation between an individual’s
acceptance of mental illness and a subsequent lack of a sense of control over his or her
life (Warner et al., 1989). In other words, the admission of having a mental illness results
in feelings of inability to be, or remain, in control of one’s life, especially in the presence
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of the ongoing paternalistic model of treatment that continues to exists in the mentalhealth field today (Warner et al., 1989). A lack of sense of control in life may, plausibly,
lead to a feeling of disempowerment. Based on this example alone, educating individuals
about their illness, something that most clinicians today feel is one aspect of empowering
their clients, apparently can also have deleterious effects. These effects include nonadherence to treatment recommendations, such as medications, appointments for therapy,
and follow-up with medical professionals (Warner et al., 1989).
However, some evidence also strongly supports the importance of helping
individuals understand their illness and its potential impact on their lives. In a study
conducted by Resnick et al. (2005), the concept of recovery was measured by analyzing
data from the Patient Outcomes Research Team (PORT) client survey to identify client
and service use variables associated with a recovery orientation. Specifically, the
researchers analyzed four factors: life satisfaction, hope and optimism, knowledge about
mental illness and services, and empowerment. Using multiple regression models, the
study found that in each model the strongest relationship occurred between an
individual’s recovery orientation and their lower reported severity of depressive
symptoms (Resnick et al., 2005). Regardless of the presence or experience of psychotic
symptoms in individuals with schizophrenia, those who reported greater depression were
less likely to endorse feelings of empowerment or recovery. Congruent with that finding
was the discovery that psychotic symptoms were associated with less life satisfaction. In
addition, knowledge about mental illness was correlated to receipt of day treatment and
legal services. As the authors predicted, and in line with other findings in the literature,
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the severity of psychiatric symptoms was negatively correlated with the development of a
recovery orientation. Furthermore, the use of a variety of services and approaches was
positively related with a recovery orientation (Resnick et al., 2005). Their conclusion
suggested that the biomedical and recovery views of mental illness, once thought to be
mutually exclusive, actually appeared to be mutually reinforcing. A combination of the
two approaches seems to be most effective in the treatment of individuals with SMI.
Therefore, if both the medical and the person-centered, recovery-oriented models of
treatment are necessary to the recovery of an individual diagnosed with SMI, then the
current method of mental healthcare must be reformed to include both aspects. The
transformation of the mental-health system suggests the importance of integrating the two
models in order to have improved treatment outcomes for individuals diagnosed with
serious psychiatric disabilities.
The conclusions drawn from Resnick et al.’s (2005) study highlight the
importance of assisting individuals with SMI in understanding the effect of their illness
on their ability to participate in other activities generally considered to be part of a
recovered and empowered lifestyle. Clinicians can use this information to guide
treatment planning to increase consumers’ likelihood of buying into and remaining in
treatment that may actually prevent premature termination of treatment. To do so,
clinicians can assist the consumer to reframe disempowering beliefs that having a mental
illness and requiring treatment in a mental-health facility, whether outpatient or inpatient,
prevents them from actively pursuing treatment involvement and inclusion in decision
making. Instead, this understanding can serve to increase consumers’ sense of
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empowerment and, therefore, improve their treatment outcomes. By accepting the reality
of having a mental illness, consumers who seek recovery-oriented treatment can feel
empowered because they are able to remain in partnership with their providers to
determine the best course of action, and thereby increase their adherence to treatment.
Predictors and Correlates of Empowerment
Some studies have investigated predictors of empowerment. Rogers et al. (1997)
were one such team who conducted statistical analyses to determine the best predictors of
global empowerment. They examined the respondents’ age, gender, educational status,
ethnicity, age at first psychiatric contact, work status, total income per month, and total
number of lifetime psychiatric hospitalizations. After running two stepwise multiple
regressions, only the respondents’ total monthly incomes emerged as a significant
predictor of empowerment (Rogers et al., 1997). Resnick et al. (2005) also correlated the
amount of medication side effects and family’s level of understanding of the illness as
factors that are predictive of empowerment. Another regression used the respondents’
reported quality of life, community involvement, number of traditional mental-health
services received, social support systems, and satisfaction with a self-help program.
According to the results, the most useful predictors of empowerment were items
measuring the quality of life, community engagement, the number of traditional mentalhealth services received, and overall life satisfaction.
Among individuals who were working, a significant relationship was found
between the number of on-the-job hours and empowerment. Income and earning power
have been linked to actual power, and access to monetary resources is considered the
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second leg of empowerment (Rogers et al., 1997). The first leg that is considered critical
to empowerment has already been discussed in a previous section. Not surprisingly, the
amount of reported self-efficacy and self-esteem, along with one’s optimism and
perceived control over the future, is considered the most important aspect that must be
present in order for an individual to feel empowered. Thus, the first leg of empowerment
can be conceptualized as a sense of self-worth and belief that one’s destiny and future life
events are within one’s control and capability. The third and final leg of empowerment
includes righteous anger and community activism (Rogers et al., 1997). In other words,
the ability to use the experience of anger over the maltreatment of individuals with SMI
and the lack of resources to meet the needs of this population to create change on a
sociopolitical level is thought to comprise this final leg of empowerment.
There appear to be many roads to empowerment, and research continues to build
an evidence base of its predictors and its outcomes. However, consensus is lacking on
how to define and, ultimately, how to conceptualize this important construct. The
evidence presented in the literature continues to strongly suggest that individuals with
SMI are more positively responsive to treatments that focus on the client as capable of
being in control of his or her life. Furthermore, a paradigm shift in the belief that SMI is
like any other illness, one from which individuals may recover, has created a need to
reevaluate the delivery of services from all mental-health professionals. The therapeutic
relationship and alliance is one logical place to start this shift.
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Therapeutic Relationship in Mental-Health Treatment
Interest in the therapeutic relationship among researchers and clinicians alike has
increased over the last several decades (Horvath & Bedi, 2002). In order to understand
the continued research interest in this construct, several factors should be considered.
First, a breadth of evidence suggests that different forms of psychotherapy produce
similar benefits in patients (Stiles et al., 2004). Thus, the majority of clinicians accept
that a large part of what the patient finds helpful in effecting change in thought and
behavior patterns is shared among various treatment modalities (Horvath & Bedi, 2002).
Therefore, focus on the generic factors that are found in most psychotherapies would
obviously include the quintessential common ground of the therapeutic relationship
(Horvath & Bedi, 2002).
Other reasons cited for the renewed interest in the therapeutic relationship can be
traced to the impact of the person-centered theory developed by Rogers. This theory
placed the therapeutic relationship at the core of the patient’s healing process. In
addition, it generated a large amount of literature that explored the interpersonal aspects
of treatment. Other theoretical models, such as the psychodynamic and experiential
perspectives, also focus on the relationship as the curative factor of the therapist-client
interaction. Despite the assertion that the relationship is the necessary and sufficient
factor for change in therapy, a lack of empirical validity for these claims apparently has
lessened the influence of these models of the therapeutic relationship.
Finally, the concept and importance of the alliance has found ready use and
acceptance in efforts to move toward an integration of the rise of theoretical eclecticism
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that appears to have entered the field of psychology (Castonguay, 2000; Castonguay &
Goldfried, 1994). In other words, with attempts to move toward theoretical integration
and reconciliation of many of the therapeutic methods that remain in conflict with one
another, researchers of varying theoretical backgrounds have been successful in
integrating this concept into their integrated framework for therapy (Orlinsky & Howard,
1986). While the definition of empowerment continues to evolve, the literature on
working alliance, or therapeutic alliance, has reached robust findings. This section will
define therapeutic alliance, discuss the importance of a working relationship between the
therapist and the consumer, and review both the therapist and the client factors related to
an effective alliance.
Definition of Therapeutic Alliance
The therapeutic alliance is not synonymous with the therapeutic relationship.
Therapeutic or working alliance has been defined as the relational, emotional, and
collaborative cognitive connection between the client and the therapist (Johnson, Penn,
Bauer, Meyer, & Evans, 2008; Karver, Handelsman, Fields, & Bickman, 2005).
Specifically, it refers to the bond between the client and therapist and is recognized by the
sense of trust the patient has in the therapist, a sense of feeling allied, and having a
positive working relationship (Karver et al., 2005). Bordin (1979) was the first to
postulate that a positive therapeutic alliance has three areas of agreement between the
client and the patient: (a) the goals of treatment, (b) the tasks to achieve these goals, and
(c) the personal bond between the two parties. Alliance is more than simply the degree to
which the client is involved in accomplishing specific treatment tasks. In other words,
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the alliance involves the role expectations of each party in the treatment (i.e., the therapist
and the consumer), and their ability to form an attachment to one another. Bordin
conceptualized the therapeutic alliance as the mutual agreement of the patient and
therapist on the goals of the treatment, in which both parties agree on the tasks each is
going to perform in the context of the relationship, and as the development of an
attachment bond (Bordin, 1979; Summers & Barber, 2003).
Bordin saw the therapeutic alliance as something that developed over time in the
relationship between the patient and the therapist. In addition, he believed that the
alliance, and not just mere empathy or untargeted transference, was the vehicle through
which all psychotherapies are effective. Finally, Bordin suggested that different
theoretical models of therapy use different aspects of the therapeutic alliance and at
different points over the course of the treatment (Bordin, 1979; Summers & Barber,
2003). Based on this definition of the therapeutic alliance, the onus of the responsibility
in the treatment is not solely reliant on the consumer to listen to and enact certain
behavioral changes to have effective outcomes. The onus of the responsibility is also on
the practitioner to foster a strong alliance to ensure that the most efficacious outcomes are
attainable.
Importance of Alliance in the Therapeutic Relationship
Psychotherapy research has emphasized the curative aspects of the therapeutic
relationship for many years (Marmarosh et al., 2009; Norcross, 2002). A sizeable
amount of literature supports assertions that the quality of the therapeutic alliance is
predictive of the therapeutic outcome (Horvath & Greenberg, 1989; Marmarosh et al.,
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2009). For example, outcomes research focusing on the therapeutic alliance has
demonstrated that patients who are satisfied with their care have a greater likelihood of
reporting greater self-confidence, being more motivated in their daily lives, practicing
healthy behaviors, and following medical advice (Conboy et al., 2010; Greenfield,
Kaplan, Ware, Yano, & Frank, 1988). In addition, they report having greater confidence
in their practitioner, thus maximizing other nonspecific healing mechanisms (Conboy et
al., 2010).
Evidence also suggests that the patient-therapist relationship may influence the
patient’s health status, as the relationship serves as a primary bond and offers a form of
social support to the patient (Conboy et al., 2010; Kaplan, Greenfield, & Ware, 1989).
The positive impact of the patient-therapist relationship on health status is important to
note, as high perceived or actual support has been linked to improved health outcomes in
human and animal studies (Conboy et al., 2010). Furthermore, patients who are less
satisfied with their care are more likely to drop out of care, change practitioners, and
report mistrust of their practitioner. These factors have been shown to undermine other
aspects of the medical encounter that might be seen as adequate by the patient (Conboy et
al., 2010). Therefore, providers of treatment must develop an awareness of their ability
to align with consumers, as the quality of the connection may have a significant impact
on the consumer’s recovery.
Overall, the therapeutic alliance plays an important role in the therapeutic process.
Of meta-analyses and narrative reviews on the role of the therapeutic alliance, across
diagnoses, 66 to 70% have found a significant association between treatment outcomes
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and the working alliance that develops over time with one continuous provider (Luborsky
& Auerbach, 1985; Orlinsky, Grawe, & Parks, 1994). Green et al. (2008) suggested that
individuals with SMI are particularly in need of continuity in their care because of the
interference from their symptoms, associated memory problems, and other cognitive
deficits related to their illness. These illness-related interferences create difficulty for the
patient to be an active participant in his or her treatment (Green et al., 2008). Therefore,
the quality of the alliance is important in establishing long-term therapist-client
relationships. The strength of the relationship is an important predictor of outcomes in
individuals with SMI.
In a study conducted by Barber, Connolly, Crits-Christoph, Gladis, and Siqueland
(2009), the relationship among therapeutic alliance, treatment outcome, and early-intreatment symptomatic improvement was measured in a group of 86 patients with various
diagnosed mental illnesses. The results suggested that although alliance in early
treatment could be influenced by prior symptomatic improvement, the alliance was found
to be a significant predictor in the patients’ further improvement when controlling for
depression (Barber et al., 2009). The authors further stated that the role of the alliance as
a potential causal factor in improvements remains consistent with the current theoretical
and therapeutic role that has been suggested for alliance by previous researchers (Horvath
& Bedi, 2002; Horvath & Greenberg, 1989; Horvath & Symonds, 1991).
Therapeutic Alliance and Treatment Outcomes
Qualitative and phenomenological research into the processes that positively
influence the therapeutic relationship allows for the greater understanding of the factors
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in therapy that enhance or reduce outcomes (Helmeke & Sprenkle, 2000). For example,
qualitative studies have demonstrated that the more a practitioner responds to a service
user’s expressed practical needs, particularly in a timely manner, the greater the amount
of trust the individual feels for the practitioner (Angell, 2012). The consumer is thought
to trust the practitioner because swift follow-through communicates respect and
understanding to the service user; the practitioner acknowledges that the needs of the
service user are important. Therefore, the strength of the relationship increases, along
with the likelihood that the service user will engage in treatment (Angell, 2012). The
converse is also true – when practitioners fail to follow through on specific tasks that they
have promised to do, service users report a tendency to disengage because they feel that
their service providers have let them down and that they are unimportant to their
practitioner.
Other qualitative studies have demonstrated that the manner in which clinicians
communicate with their clients is integral to the development of the alliance and,
therefore, the likelihood of positive follow-through in treatment and in outcomes (Angell,
2012; Kreyenbuhl, Nossel, & Dixon, 2009). Studies also show that using the consumers’
own language to explain the symptoms they may be experiencing enhances the
therapeutic relationship and treatment engagement (Angell, 2012). Furthermore, studies
also demonstrate that by listening to consumers and allowing them to express their
preferences for treatment, the practitioner can enhance the therapeutic relationship
(Angell, 2012).
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Despite the literature suggesting a strong relationship between effective working
alliances on the treatment outcome of individuals with mental illness, few investigators
have been able to answer the question of the predictive ability of the working alliance on
subsequent change in symptoms or improved treatment outcomes (Barber et al., 2009).
In fact, some studies have not been successful in demonstrating this relationship, but
instead found that the alliance did not predict decreases in depression or substance abuse
(DeRubeis & Feeley, 1990). These contradictory findings regarding the effects of the
therapeutic alliance suggest that the primary factor for the predictive capability of the
therapeutic alliance is the patient’s perception of the relationship (Horvath & Bedi, 2002).
Researchers have discussed the belief that nonspecific factors are important in the
therapeutic process, particularly in outcomes-based research, which measures the
collaboration and bond that are established between the consumer and the therapist
(Barber et al., 2009; Castonguay, 2000; Conboy et al., 2010; Gaston, 1990). However,
though rarely discussed in the literature, a positive therapeutic alliance early in treatment
might be associated with a change in a patient’s mood that has already occurred as a
result of the therapy; thus, the patient may tend to view the therapist and the treatment
positively, particularly if he or she has already experienced an improvement in mood
(Barber et al., 2009). When considering this alternative view, one must determine if the
positive therapeutic alliance is a predictor of positive treatment outcome, of the early
treatment improvement, or of some interaction between these two factors (Barber et al.,
2009). Therefore, this study will seek to corroborate or provide more information about
the predictive nature of alliance.
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The facilitation and development of respect that grow out of developing a strong
positive therapeutic alliance seems to be an important factor in the positive treatment
outcomes discussed throughout the literature on this topic. Health professionals’ attitudes
toward people diagnosed with SMI play an important role in the reduction of stigma and
discrimination. Treating individuals with respect and dignity, and taking time to
understand the needs and wants unique to the individual, are essential to the development
of good therapeutic alliance (Barber et al., 2009). When the therapeutic alliance is built
on a foundation of respect and dignity, the individual will engage more readily in the
treatment process and feel more connected to the actual recommended treatment
modality. Interestingly, in a study researching the distribution and association between
specific mental illnesses and negative attitudes of mental-health professionals, individuals
diagnosed with SMI were more likely to be perceived as being incapable of recovery and
tended to be blamed for their mental illness (Crisp, Gelder, Rix, Meltzer, & Rowlands,
2000).
One can argue that an individual will be most likely to gain and maintain positive
treatment outcomes by remaining in treatment. For example, literature supports the
positive outcome for homeless individuals diagnosed with SMI in the presence of a
strong therapeutic alliance with their case management teams (Chinman, Rosenheck, &
Lam, 2000; Solomon, Draine, & Delaney, 1995). Additionally, in a study investigating
whether premature termination of treatment for psychosis using cognitive behavioral
therapy (CBT) was related to a person’s recovery style and the therapeutic alliance,
researchers found that individuals were more likely to drop out of treatment prematurely
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if they disagreed on the goals and tasks of the treatment, as assessed by the Working
Alliance Inventory (WAI) scale (Startup, Wilding, & Startup, 2006). Interestingly, those
who dropped out of the treatment did not differ significantly in the Bond subscale of the
WAI from those who remained in treatment. McGlashan (1987) argued that the goal of
treatment should, therefore, not focus on altering the individual’s personal recovery style,
but to match treatment to the person’s presenting style. This suggests the importance of
alliance in the relationship, perhaps the greatest predictor of success in treatment.
The importance of the therapeutic alliance continues to be reviewed in the
provision of psychotherapeutic treatments because, as previously noted, much of the
treatment success relies on this aspect of care. Perhaps a corollary to the therapeutic
alliance is the clinician’s willingness to include the consumer in the process of treatment
planning. The following section will review the current literature on participatory
decision making. In particular, this section will discuss the definition of participatory
decision making, the factors that are believed to contribute to this style of interaction, and
the contribution this form of inclusion has on treatment outcomes.
Participatory Decision-Making
During the past several decades, the idea that patients should be involved in the
decision-making process of treatment has arisen from advocacy efforts of the very
consumers who are receiving the treatment. Involving individuals in treatment decision
making is also garnering greater interest with the increasing pressure from insurance
companies and professionals in the field to use evidenced-based treatment in treatment
planning (Elwyn et al., 2001; Warner, 2009). Research evidence demonstrates that the
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desires and choices of clients who have not been informed of choices in treatment change
once they have been educated on both the benefits and the potential harms of different
treatment options (Elwyn et al., 2001; Wolf, Nasser, Wolf, & Schorling, 1996).
Furthermore, if the clinician involved in the relaying of this information is skilled and
sensitive to the individual needs and concerns of the patient, this change in choices is
more likely to occur (Wolf et al., 1996). In reality, a patient’s right to autonomy and selfdetermination will influence the clinician’s proposed treatment plan even after the patient
has been informed of his or her options. Through the model of participatory decision
making (PDM), understanding this reality is critical to deciding how the clinician will
collaborate with the patient (Elwyn et al., 2001). The need to honor patient’s right to
autonomy suggests to clinicians in the field the importance of understanding how
inclusion in decision making can best be employed in order to increase the likelihood for
successful treatment. The following presents a definition for inclusion in treatment
decision making, also known as participatory or shared decision making.
Definition of Participatory Decision Making (PDM)
PDM between a practitioner and the consumer of the services refers to the amount
of communication that is fostered by the clinician with the patient regarding the direction
of the treatment (Street, Makoul, Arora, & Epstein, 2009). It denotes an interactive
process during which clients and practitioners collaborate in order to make healthcare
decisions (Adams & Drake, 2006). This collaboration assumes that both parties have
important information to contribute to the treatment process. The practitioners hold
information about the current and correct diagnosis, course of illness, treatment options,
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moderating factors, and evidence-based information regarding and side effects of the
different treatments (Adams & Drake, 2006). Likewise, the clients are the experts on
their own values, treatment preferences, and goals for treatment (Charles, Gafni, &
Whelan, 1997).
A crucial aspect of PDM is the presence of the patient’s right to choose; the
consumer makes decisions regarding the roles and the level of participation he or she will
assume (Adams & Drake, 2006). If viewing choice as a spectrum with two opposing
ends, then clients may fall along the continuum at different points. For instance, at one
end, clients may adopt a dominant role in which they make the decisions and the
practitioner merely provides the information on the risks and benefits. At the other end
of the spectrum, the clients may opt to defer decision-making power and abrogate
control, giving sole responsibility to the practitioner (Elwyn & Edwards, 2001).
However, many clients choose a more balanced role in decision making. They prefer to
engage in a dialogue with their practitioner about the treatment issue and reach a
consensual agreement on treatment approach (Adams & Drake, 2006).
PDM, in general, involves a shared responsibility for developing and meeting
treatment goals. A consumer with a possibly longer term illness, such as SMI, must learn
to accept the need to take responsibility for his or her own care on a daily basis. For
example, the consumer must remember to take medications not only for the mental
illness, but also for any other medical illnesses for which medications may be prescribed.
This part of gaining and/or maintaining wellness is essential. Given this example,
however, both the practitioner and the client must keep in mind that the client’s
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perspective, capacity to make changes, and role will change over time (Adams & Drake,
2006). As has been outlined in the stages of change theory, a process of acceptance and
responsibility is usually present in an individual who learns to manage a chronic or longer
term illness (Prochaska, DiClemente, & Norcross, 1992). However, according to the
current medical models of treatment for chronic and long-term illnesses, the clinician
continues to be the client’s guide in making choices about living with the condition and
making an optimal adaptation (Adams & Drake, 2006; Auerbach, 2001). By
participating in making healthcare decisions, or sharing the decision-making tasks, the
client will most likely increase his or her engagement in treatment, and his or her
“knowledge, confidence, skills, and commitment to making an optimal adjustment”
(Adams & Drake, 2006, p. 88).
Factors Related to a PDM Style
Therapist variables. Research suggests that practitioners who present options to
consumers, who discuss thoroughly the pros and cons of the options, who elicit the
consumers’ preferences, and who establish mutually agreed-upon goals are said to have
employed a PDM style (Kaplan, Greenfield, Gandek, Rogers, & Ware, 1996). These
treatment providers are thought to have greater success in their alliance with their
patients, which may result in better treatment outcomes when compared to physicians
who have a more controlling decision-making style (Kaplan et al., 1996).
Research also suggests that practitioners’ sense of autonomy is an important key
in the use of an inclusive decision-making style (Adams & Drake, 2006; Kaplan et al.,
1996). Kaplan et al. (1996) determined that physicians who reported being satisfied with
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the amount of personal autonomy they experienced in their jobs and who reported
practicing independently were rated as more participatory than physicians who were not
satisfied. Therefore, if personal autonomy is related to a more inclusive treatment style,
then physicians’ perceptions of more control in their practice are more likely to engage in
a PDM approach to treatment. Furthermore, practice situations that encourage a sense of
autonomy may enhance the quality of interpersonal care that the physician is providing
(Kaplan et al., 1996). Practice volume may have a large impact on the ability of
physicians to interact in an inclusive treatment style because physicians in busy practices
may be unable to spend the time that is necessary to develop rapport and allow for the
free discussion of questions about treatment, treatment options, and preferences for
treatment approach (Kaplan et al., 1996). Therefore, the quality of interpersonal care
may be underestimated as a consequence of practice volume (Kaplan et al., 1996).
In addition to perception of autonomy, a physician’s race had an impact on
patients’ perceptions of inclusion. For example, in the Kaplan et al. (1996) study,
nonwhite physicians were reported to be less participatory than their white counterparts
after adjusting for the greater practice volume of nonwhite physicians. Kaplan et al.
(1996) did not publish their thoughts about the reason for this apparent discrepancy,
though they did recommend that future efforts should explore cultural differences that
may have impacted the physician’s interpersonal style and technical care. However,
underlying multicultural and diversity issues may have an impact on the experience of the
patient, or the practitioner may also practice with a more exclusionary style.
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Consumer variables. Research on the interaction between medical doctors and
their patients has demonstrated that consumers who feel they have an active part in their
treatment decision making are more likely to follow through on those decisions than
those who do not have an active role (Kaplan et al., 1996). This apparent relationship
between treatment engagement and inclusion in treatment decision making has particular
relevance for practitioners who treat individuals with a chronic or longer term illness, as
the majority of the treatment plan must be carried out by the consumers (Kaplan et al.,
1996). In order for maximum treatment effectiveness, the consumer needs to commit to
working daily on his or her treatment plan and recommendations. In addition, patients
who ask more questions of their doctors, who elicit treatment options, and who express
their treatment preferences during their visits with their physicians have measurably
better health outcomes than those patients who are more passive in their interaction style
(Kaplan et al., 1996). Although the previously cited literature focused on the
communication style of physicians in the medical realm of practice, and not on therapists
or behavioral-health professionals, the information is at least relevant to the
understanding of the importance of inclusion in treatment planning. There is a dearth of
literature that focuses specifically on the construct of PDM in the behavioral-health
profession. Therefore, results from this study will increase the current literature that
exists about this important concept.
PDM Style and Treatment Outcomes
Physicians are encouraged to adopt a treatment style that involves the consumer in
decision making because the evidence from the medical literature suggests that this
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approach can help a patient gain control of a chronic disease and experience greater
functional outcomes (Shields, Franks, Fiscella, Meldrum, & Epstein, 2005). However, to
date the evidence for these outcomes is mixed (Adams & Drake, 2006). Literature,
though sparse, supports both the self-reported improvement of functioning in individuals
and the lack of improvement in outcomes related to illness management when a treating
physician uses a PDM style. Improvements in functioning are generally related to the
reported reduction in psychological distress that has become associated with the
practitioner’s provision of information and adoption of a more client-centered
communication style (Kiesler & Auerbach, 2003). Clients who are under the care of a
practitioner who engages in a PDM style reported more satisfaction in their care than a
control group whose practitioners did not utilize a PDM style (Adams & Drake, 2006).
Although perceived PDM is associated with positive outcomes, the results appear to be
related solely to the clients’ perceptions (Greenfield et al., 1985). Rogers, Vergare,
Baron, & Salzer (2007) have suggested that providers’ anticipation of clients’ treatment
“failure” may prevent the development of a sense of ability to take risks and pursue
meaningful goals. The positive impact of a PDM style suggests the need for further
understanding of ways providers can engage individuals in their treatment, including
getting a better understanding of what the individuals’ goals are and communicating
clearly with the individuals through a process of informed consent and inclusion in the
process (Epstein, Alper, & Quill, 2004).
Studies that have been conducted on patients’ perceptions of their physicians’
efforts to include them in the decision-making process have reported greater patient
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satisfaction, better self-management of the illness, increased likelihood that the patient
will request information about alternative or complementary treatments, decreased need
for hospitalization, and better health-related quality of life (Heisler, Bouknight, Hayward,
Smith, & Kerr, 2002; Kaplan et al., 1996; Sleath, Callahan, Devellis, & Beard, 2008).
Additionally, communication styles appear to be related to PDM style. In a study that
measured cancer survivors’ perceptions of their treating physicians’ tendencies to utilize
a PDM style, researchers found that physicians’ PDM style was significantly related to
proximal communication about the treatments and illness, intermediate cognitive
outcomes, and distal health outcomes. Furthermore, survivors were more likely to feel
and be more confident in actively participating in the treatment decision-making (Neeraj,
Weaver, Clayman, Oakley-Girvan, & Potosky, 2009). In the same study demonstrated
that use of a more inclusive style of decision making by the physician may be associated
with better mental health by both increasing survivors’ perceptions of personal control
and enhancing the level of trust between the physician and the patient (Neeraj et al.,
2009). Therefore, although a gap remains in the literature demonstrating the connection
between PDM and empowerment, as suggested by Street et al. (2009) and results from
the previously mentioned study, physicians who involve their patients in the process of
treatment are more likely to increase and enhance their patients’ sense of self-efficacy for
interacting with their physicians.
PDM Style and Treatment Engagement
The medical field has been studying the benefits of adopting and using an
inclusive decision-making style for a longer duration and in more depth than has the
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behavioral-health field. Previously unchecked power differentials between physician and
patient resulted in a culture of belief that the patient was to be seen as a passive recipient
of decisions that were made by the physician (Auerbach, 2001). However, with the rise
of awareness and dissemination of recovery-oriented approaches to treatment, the
paternalistic approach has been challenged on both the ground level and by policymakers, calling for increased inclusion in treatment decision making by the patient
(Auerbach, 2001; see New Freedom Commission on Mental Health, 2003a/2003b).
Since these challenges, both medical professionals and lay people have argued that
patients should be fully informed of important medical information and be active
participants in their care (Auerbach, 2001). This change was made in order to correct, or
balance, the misappropriated power differential. Although the behavioral-health field has
been slow to include this important concept into the provision of care and delivery of
services, the call to action since the development of the Recovery to Practice Initiatives
and Guidelines has brought into light the value and validity of this approach in delivery
of treatment services.
Using an inclusive approach to treatment planning implies care and concern about
the patient’s needs, desires, and wishes. It also implies the active engagement of patients
by treating clinicians in all areas of decision making and involves, at a minimum, a
clinician and the patient, as well as other members of the patient’s family and/or support
network. Shared decision making requires both parties in the relationship to share
information, where the clinician provides information about the options and the potential
risks and benefits and the patient makes an informed decision of the course of treatment
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(Barry & Edgman-Levitan, 2012). Research results investigating the effectiveness of
increasing treatment engagement of individuals with SMI are mixed. In a meta-analysis
conducted by Cochrane Systems reviewing the primary and secondary effects of
inclusion in decision making between inpatient individuals diagnosed with schizophrenia
and individuals in primary care newly diagnosed with depression, no evidence of effect
on clinical outcomes or hospital readmission rates was found in either population.
Furthermore, the intervention did not increase patients’ compliance with their treatment
plans. However, some evidence suggested that interventions that were introduced to
increase shared decision making did positively affect physician facilitation of patient
involvement in decision making and did not require longer consultation times (Duncan,
Best, & Hagen, 2010). The consensus of the researcher was that no firm conclusions
could be drawn from the two sample populations that were used in the research.
However, of note, the results indicate the need for further research into the potential
benefactors of satisfaction with received treatment and engagement in the treatment.
In another meta-analysis conducted by the group, two studies of relatively good
quality were identified and then examined for the impact that a clinician’s use of an
inclusive decision-making style had on treatment outcome satisfaction, health outcomes,
and readmission rates (Duncan et al., 2010). In one of the two studies, the intervention
had a short-term positive effect on satisfaction with the treatment. In the other study,
consumer involvement in the decision-making process was increased when the physician
led the intervention. Of note, no effects were obtained on the clinical and health service
outcomes in either of the studies. The lack of sufficient evidence regarding the use of an
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inclusive decision-making style suggests that further research is needed to determine the
impact that shared decision making has on engagement in treatment.
Self-Efficacy, Empowerment, Alliance, and PDM Style in Individuals with SMI
Evidence supports the importance of having a PDM style for treatment success in
the provision of mental-health services. However, both the clinician and the consumer of
services contribute to the development of this important style of communication. In order
to best set the foundation for treatment success in individuals with SMI, issues of selfefficacy, consumer empowerment, development of a strong therapeutic alliance, and
inclusion in treatment decision making are several necessary components that must be
considered. Although literature examines these constructs individually, or with other
aspects of treatment outcomes, no studies have evaluated the interaction of these four
variables on perceived treatment outcome for an individual with SMI.
In lieu of the mandate to transform the delivery of behavioral-health services in
the United States, the constructs in this study represent an attempt to better understand
the constructs and the processes that yield effective treatment outcomes in the presence of
a recovery-oriented approach to treatment. Therefore, this study seeks to determine the
relationships among and the relative contributions of the constructs of empowerment,
therapeutic alliance, self-efficacy, and PDM style on the treatment outcomes in
individuals diagnosed with SMI. In addition, this study seeks to better understand how
these three constructs interact with and influence one another (see Figure 1)2. There is a

2

Anticipated relationships are that overall global empowerment and the working alliance will predict perceived efficacy in patients’
interactions with their physicians, a more specific variable. Additional expected relationships are that overall empowerment (ES), the
working alliance and perceived efficacy in interactions with physicians will predict inclusion in treatment decision making. All of
these constructs will be predictive of perceived treatment outcomes operationalized as satisfaction with treatment.
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ES
PEPPI

PDMS

MHSIP

WAI

Figure 1. Conceptual model of hypotheses 1, 2, and 3. ES = Empowerment Scale; WAI
= Working Alliance Inventory-Client Version, Short Form; PEPPI = Perceived Efficacy
in Patient-Physician Interaction Scale; PDMS sum = Participatory Decision-Making
Scale (sum score); MHSIP sum = Mental Health Statistics Improvement Program (sum
score).

dearth in the literature to explain the relationship between empowerment and PDM,
empowerment and satisfaction with received treatment, and treatment specific selfefficacy and empowerment. Results from this study will provide important information
that will help to guide program development and training for clinicians providing services
to the individuals and to guide future research on effecting positive treatment outcomes
for individuals with SMI. Furthermore, the information specifically related to the impact
of consumer rated perceptions of empowerment will serve to increase the current
literature about this dynamic construct. Finally, anticipated results will assist those
providing behavioral-health services to individuals with SMI to better conceptualize the
factors that are more likely to result in consumer follow-through of treatment planning,
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particularly in relation to the required transformation that is occurring in the delivery of
mental-health services.
Classes of Predictors
These correlates of treatment outcomes can be categorized into several classes of
predictors that can be conceptualized as within or internally based, like a trait versus state
characteristic, and externally based or process-related variables. For the purposes of this
study, the construct of empowerment should be considered a trait-specific characteristic,
where the individuals’ sense of global empowerment is measured by the Empowerment
Scale. Additionally, the construct of self-efficacy should be considered to be a statespecific characteristic, in that the individual’s sense of self-efficacy is context dependent
on his or her perception of the effectiveness of interactions with physicians. Self-efficacy
is measured by the Perceived Efficacy in Patient-Physician Interaction Scale. The
construct of PDM should be considered an external variable that is reliant on the
physician/clinician’s style of more or less inclusion afforded to the client in treatment
decision making. PDM is measured by the Participatory Decision-Making Scale. Finally,
the construct of therapeutic alliance should also be considered to be a process-related
external dependent variable, such that the therapeutic alliance requires by definition the
bond that develops between the therapist/clinician/physician and the individual. The
therapeutic alliance is measured by the Working Alliance Inventory-Client Version-Short
Form.
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Chapter 3: Hypotheses
Research Question 1
What is the relative contribution of the therapeutic alliance and global
empowerment to patients’ perceived self-efficacy in their interactions with their
physicians? Does the working alliance, as measured by the Working Alliance InventoryClient Version, Short Form (WAI-C-S), and perceived global empowerment, as measured
by the Empowerment Scale (ES), predict patients’ perceived self-efficacy in their
interactions with their psychiatrists, as measured by the Perceived Efficacy in PatientPhysician Interactions Scale (PEPPI)?
Alternative Hypothesis 1
High levels of self-reported working alliance and global empowerment are
positively correlated to greater reports of perceived self-efficacy in patients’ interactions
with their psychiatrists.
Null Hypothesis 1
High levels of working alliance and global empowerment will not be significantly
related to high levels of reported perceived self-efficacy in interactions with psychiatrists.
Justification for Hypothesis 1
The importance of the working alliance in therapeutic interactions has been
repeatedly documented as an important predictor in therapeutic outcome (Barber et al.,
2009; Green et al., 2008; Pos, Greenberg, & Warwar, 2009). For individuals with SMI,
this relationship can be difficult to secure at times and can take longer to develop (Barber
et al., 2009). The therapeutic alliance has been linked to greater reports of self-efficacy
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in individuals diagnosed with SMI (Rogers et al., 1997). Thus, individuals’ reports of
greater therapeutic alliance should result in higher endorsement of self-efficacy when
interacting with their physicians.
Summary of Relevant Work
The relevancy of the construct of therapeutic alliance in the ability of an
individual with SMI to recover and lead a meaningful and productive life has been a
large focus of the treatment of mental illness (Horvath & Bedi, 2002; Horvath &
Greenberg, 1989; Horvath & Symonds, 1991; Pos et al., 2009). When therapy begins,
clients respond globally to the experience by their desire to be listened to and to engage
in the therapeutic process. Without these needs being sufficiently met in a timely
manner, there is a risk of early termination (Horvath & Bedi, 2002). In a study conducted
by Barber et al. (2009), results suggested that although alliance in early treatment could
be influenced by prior symptomatic improvement, the alliance was found to be a
significant predictor in patients’ further improvement when controlling for other potential
comorbidities (Barber et al., 2009). Therefore, for individuals with SMI, the perceived
therapeutic alliance is an important construct to measure in order to achieve the goal of
recovery from psychiatric disability.
Research Question 2
To what extent does perceived self-efficacy in interactions with psychiatrists,
perceived global empowerment, and perceived therapeutic relationship predict patients’
perceptions of inclusion in treatment decision making? How does individuals’ perceived
self-efficacy in interactions with their psychiatrists, as measured by the Perceived
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Efficacy in Patient-Physician Interactions Scale (PEPPI), perceived global empowerment,
as measured by the Empowerment Scale (ES), and perceived therapeutic alliance, as
measured by the Working Alliance Inventory-Client Version, Short Form (WAI-C-S),
impact on a patients’ perceptions of inclusion in treatment decision making, as measured
by the Participatory Decision-Making Scale (PDMS)?
Alternative hypothesis 2
Individuals who report higher levels of perceived self-efficacy in interactions with
their psychiatrists, higher sense of global empowerment, and greater alliance with their
clinicians will report greater sense of inclusion in treatment decision making. Individuals
who report low levels of perceived self-efficacy when interacting with their psychiatrists,
low global empowerment, and minimal alliance with their clinicians will report not
feeling included in making treatment decisions.
Null Hypothesis 2
The level of perceived self-efficacy and therapeutic alliance individuals
experience with their psychiatrists and the level of global empowerment that individuals
experience in their daily lives will not be correlated with their sense of inclusion in
treatment decision making.
Justification for Hypothesis 2
Physicians are encouraged to adopt a treatment style that involves the individual
in the decision-making process because of the evidence in early literature that suggests
that this approach can help a patient gain control of a chronic disease and experience
greater functional outcomes (Shields et al., 2005). Because of the real concern of rising
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healthcare costs for these particularly vulnerable individuals, determining any factors that
may mitigate the use of expensive crisis services is important.
Summary of Relevant Work
Self-efficacy has been linked to better treatment outcomes for individuals with
SMI (Raggi et al., 2009). It is also considered an important factor in empowering
individuals. The presence of self-efficacy is very essential when dealing with a chronic
illness because it can impact the amount of effort, perseverance, resilience, and adherence
to treatment (Raggi et al., 2009). These factors are all key in the successful management
of a chronic disease. Having a high sense of self-confidence in one’s own ability to act in
a way that will help to control symptoms of mental illness has been found to have healthenhancing effects in itself (Marks et al., 2005; Raggi et al., 2009). Conversely, having
low self-efficacy may mediate the change in disease self-management behaviors,
resulting in negative physical and mental-health outcomes (Marks et al., 2005). When
considering SMI, often a chronic disease, one can appreciate the importance of selfefficacy to outcomes is evident.
Research Question 3
What is the relative contribution of the therapeutic alliance, perception of global
empowerment, perceived self-efficacy in interactions with physicians, and inclusion in
treatment decision making to individuals’ perceived treatment outcomes? How does the
therapeutic alliance, as measured by the Working Alliance Inventory-Client Version,
Short Form (WAI-C-S), global empowerment, as measured by the Empowerment Scale
(ES), self-efficacy in interactions with physicians, as measured by the Perceive Efficacy
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in Patient-Physician Interactions Scale (PEPPI), and perception of inclusion in treatment
decision making, as measured by the Participatory Decision Making Scale (PDMS)
impact individuals’ perceived treatment outcomes, as measured by the Mental Health
Statistics Improvement Program Consumer Survey (MHSIP)?
Alternate Hypothesis 3
Perception of positive treatment outcomes in individuals diagnosed with SMI is
predicted by the therapeutic relationship, sense of personal empowerment, sense of
perceived efficacy in their interactions, and the physician’s inclusive style in treatment
decision making.
Null Hypothesis 3
The perceptions of individuals with SMI regarding inclusion in treatment decision
making, the therapeutic relationship, personal empowerment, and sense of efficacy in
interacting with their clinicians is not related to their self-reported treatment outcomes.
Justification for Hypothesis 3
Accumulating data collected from empirical studies show that patients of
physicians who approach patient care by encouraging them to participate more actively in
treatment decision making have more favorable health outcomes (Greenfield, Kaplan, &
Ware, 1985; Kaplan, Greenfield, & Ware, 1989). Furthermore, the quality of the
therapeutic alliance and the presence of personal empowerment are important factors in
an individual’s recovery from SMI (Barber et al., 2009; Resnick et al., 2005).
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Summary of Relevant Work
Evidence in research demonstrates that the desires of patients who have not been
informed of choices in treatment alter once they have been informed of both the benefits
and the potential harms of different treatment options (Elwyn et al., 2001; Wolf et al.,
1996). Furthermore, if the clinician involved in the relaying of this information is skilled
and sensitive to the individual needs and concerns of the patient, this change in desires is
more likely to occur (Wolf et al., 1996). Elwyn et al. (2001) suggested that, “any attempt
to measure involvement in decision-making should therefore consider to what degree (if
any) a health professional portrays choices and invites patients to participate in the
decisions, along with other processes that may be associated” (p. 6). Understanding that
patients’ rights to autonomy and self-determination can usurp the professional clinician’s
point of view even after they have been informed of their options is critical to deciding
how the treatment will progress (Elwyn et al., 2001).
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Chapter 4: Methods
Overview
This study sought to determine the relative contribution of empowerment, as
defined previously, and working alliance on an individual’s reported perceived efficacy
in patient-physician interactions. Secondly, this study also sought to determine the
importance of the perceived efficacy that individuals experience in their interactions with
their physicians. Finally, this study sought to determine the relationships between the
previously mentioned variables on perceived satisfaction of treatment received. The
constructs used in this research included empowerment, working/therapeutic alliance,
treatment outcomes, participatory decision making (PDM), and self-efficacy. This study
used the empowerment scale (ES), Working Alliance Inventory-Client Veresion, Short
Form (WAI-C-S), the Mental Health Statistics Improvement Program Consumer Survey
(MHSIP) scale, the Participatory Decision-Making Scale (PDMS), and the Perceived
Efficacy in Patient-Physician Interactions Scale (PEPPI) to measure these constructs.
Design and Design Justification
This study used an existing data set to assess the nature of the relationships
between global empowerment and working alliance on individuals’ perceived efficacy in
their interactions with their physicians. This study also used the existing data set to
determine the relationship between perceived efficacy and their treatment outcomes.
Data Set
This data set was part of a large longitudinal study consisting of 396 individuals
who were served at community mental-health centers throughout the city of Philadelphia.
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As a result of the large size of the data set, this study was able to answer important
questions about how the constructs of empowerment, working alliance, and self-efficacy
are correlated with the individuals’ sense of inclusion in treatment decision making and
their perceived treatment outcomes. Furthermore, using an existing data set minimized
the risk of loss of confidentiality and anonymity, as this data set consisted of information
that was deidentified.
Participants
Three hundred and ninety-six (396) participants were recruited at three area
community mental-health agencies in Philadelphia, Pennsylvania, for the original study.
These agencies included Community Organization for Mental Health and Retardation
(COMHAR), Community Council, and Hall Mercer, and agreed to work with the
research team from the University of Pennsylvania. All 396 participants completed the
baseline interviews. Data were collected from an approximately equal number of
participants at each of the participating sites. In all, 247 participants (62%) were Black,
and 149 participants (38%) were White, according to administrative records provided by
each agency. The data on racial background obtained by Salzer, Brusilovsky, Rothbard,
and Hadley (2007), client self-reported information, were different from agency-based
records in that 199 participants reported they were Black, and 123 participants said they
were White.
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Inclusion and Exclusion Criteria
Inclusion Criteria for Original Data Set
The criteria for eligibility, as determined by Salzer et al. (2007), included the
following: (a) individuals with a primary Axis I diagnosis of schizophrenia, a
schizophrenia-spectrum disorder, or major depression; (b) individuals who were
categorized as White or Black in the records of participating agencies; (c) individuals
over the age of 18 years; and (d) individuals who were receiving prescriptions for
psychiatric medication from the mental-health agency.
Exclusion Criteria for Original Data Set
Individuals who were unable to read or speak English were excluded from
participating in the original collection of the data. In addition, individuals who could not
be reached by phone call were excluded from participating in the original data collection.
Screening Procedures for Original Data Set
Screening procedures were used to verify the presence of an Axis I diagnosis of
schizophrenia or major depression. The screening process entailed having the participant
sign a release of information that would allow the research team to contact an agency
staff member, identified by the participant, to confirm the participant’s diagnosis
according to patient records.
Recruitment for Original Data Set
The research staff involved in the original recruitment procedures informed the
staff at the participating agencies of the opportunity for consumers with SMI to
participate in a research study. They then directed staff to approach their consumers to
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inform them of the study and gain their consent for research staff to contact them. A
consent to contact form was completed and then returned to the research staff. All
subjects who consented to speak to the research staff were contacted and informed about
the study. If they agreed to participate, they then provided written consent, and
completed a baseline interview, and follow-up interviews.
Plan for Informed Consent Procedures
This study used a preexisting archival data set. Therefore, this study did not
require further informed consent procedures.
Measures
Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI; Maly et al.,
1998)
The PEPPI was developed to measure subjects’ sense of perceived self-efficacy in
their interactions with their physicians. The scale assesses patients’ subjective sense of
confidence when interacting with their physicians (Maly et al., 1998). The scale is
comprised of 10 questions that were developed to measure patients’ confidence in their
ability to elicit and comprehend the information they receive, as well as to communicate
information to their physicians. It was also designed to measure patients’ confidence in
their ability to get their physicians to address and act on their reported medical concerns.
The items that are included in the scale are based on issues that older adult patients
brought to light about their interactions with their physicians in open-ended questioning
during a study of adherence with geriatric assessment recommendations, as well as the
authors’ observations of or participation in encounters between patients and their
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physicians (Maly et al., 1998). Each item of the PEPPI begins with the basic leading
question of, “How confident are you in your ability to…” Subjects respond to each
question on a Likert scale of 1 to 5, with 1 representing “not at all confident” and 5
representing “very confident” (Maly et al., 1998). Thus, the range of possible scores for
the 10-item PEPPI scale is 10 to 50, with 50 representing the highest possible amount of
patient-perceived self-efficacy. The full scale takes approximately 3 minutes to
administer, with no reported comprehension difficulties from the subjects (Maly et al.,
1998). The internal reliability coefficients (Cronbach's alpha) for the full 10-item PEPPI
scale are calculated to be 0.90 and 0.91. Thus, the PEPPI demonstrates high convergent
and discriminant construct validity (Maly et al., 1998).
Empowerment Scale (ES; Rogers et al., 1997)
This scale was developed by Rogers et al. (1997) to measure the amount of global
empowerment that mental-health consumers experienced when interacting with their
physicians during regular medication appointments. It is being used in this study to
determine the amount of perceived global efficacy or empowerment that a participant was
experiencing at the time of data collection. It consists of a 28-item, self-report survey.
The scale yields a total empowerment scale, as well as five subscale scores derived from
a factor analysis (Rogers et al., 1997). The subscales include self-efficacy-self-esteem,
power-powerlessness, community activism, righteous anger, and optimism-control over
the future (Brown et al., 2008). In two studies of reliability using Cronbach’s alpha, the
full scale yielded high internal consistency of .85 and .86; the reliability coefficients for
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internal consistency for five subscales ranged from .51 to .91 (Rogers et al., 1997; Wowra
& McCarter, 1999).
The authors developed a survey with the assistance of a consumer research
advisory board. At the beginning of the research project, 10 individuals were selected to
be a part of a consumer research advisory board (Rogers et al., 1997). These individuals
were leaders in the consumer/survivor movement and were able to represent the various
factions of that movement. The board then held several meetings to design and plan the
research study, as part of the participatory action research that is encouraged by consumer
activist groups (Rogers et al., 1997). During the meetings, the board outlined 15
attributes of empowerment, based on the definition of psychological empowerment
previously reviewed (Rogers et al., 1997). After arriving at a consensus about the
definition and its many dimensions, the board determined the items for the scale. They
were modeled after the Rotter Internal-External Locus of Control instrument, the SelfEfficacy Scale, and the Rosenberg Self-Esteem Scale (Rogers et al., 1997).
Working Alliance Inventory – Client Version, Short Form (WAI-C-S; Horvath &
Greenberg, 1989)
The WAI-C-S was used in this study to measure the perceived amount of
therapeutic alliance that the patient experienced in the interaction. This tool was
developed by Horvath and Greenberg (1989). This 36-item scale consists of a 7-point
Likert scale, anchors, and three subscales. These subscales include the degree to which
the client and therapist bond or become attached, the degree to which the client and
therapist collaborate on specific therapeutic activities or tasks, and the degree to which
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the client and therapist agree on the global objectives or goals of the therapy (Horvath &
Greenberg, 1989). Cronbach’s alpha for the total score is .92, and the subscales all have
reliability estimates that are greater than .74, suggesting adequate reliability (Horvath &
Greenberg, 1989). In order to reduce the possibility of a social desirability bias, the
participants were informed that their responses would not be shared with their respective
therapists, but would be available only to the research team (see also Salzer et al., 2007).
Mental Health Statistics Improvement Program Adult Consumer Survey (MHSIP;
Eisen et al., 2001)
The MHSIP Consumer Survey was developed with input from stakeholders
involved and connected with the Center for Mental Health Services (Eisen et al., 2001).
The purpose of the measure was to evaluate the performance of a mental-health system in
the domains of accessibility, quality and appropriateness of services, and treatment
outcomes from the consumers’ perspective (Jerrell, 2006). Satisfaction items were also
included in the scale. After the psychometric properties were analyzed, structures of
three factors were confirmed using 16 items. These include access to care, quality and
appropriateness of services, and outcomes (Jerrell, 2006). Satisfaction questions were
widely used, making the scale a 21-item survey (Jerrell, 2006). This scale is based on a
Likert scale, where 1 indicates “Strongly Agree” and 5 indicates “Strongly Disagree.”
For all of the subscales, the Cronbach’s alpha coefficients were in the good range, from
0.73 to 0.81 (Jerrell, 2006). In addition, the interscale correlation coefficients were in the
moderate range, from 0.42 to 0.58, indicating a moderate degree of independence among
the subscales (Jerrell, 2006). Finally, the Cronbach’s alpha coefficients between the
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subscale scores and the total score were consistently in the good to very good range, from
0.77 to 0.88 (Jerrell, 2006). Thus, the MHSIP Adult Consumer Survey psychometric
results indicate good internal consistency, moderate test-retest reliability, and good
convergent validity with consumer perceptions of other aspects of their overall care.
Participatory Decision Making Scale (PDMS; Kaplan et al., 1996)
The original PDMS is a three-item scale developed by Kaplan et al. (1996). It
requires patients to rate the extent to which physicians used a participatory style during
their provision of services. The PDMS measures participatory decision-making style by
asking patients to rate how often or how much the physician: 1) involves them in
treatment decisions, 2) gives a sense of control over their medical care, and 3) asks them
to take some responsibility for their care (Kaplan et al., 1996). The scale has been found
to have a Cronbach's alpha of 0.74 in prior research.
Procedure for Original Data Collection
Each participating agency created four lists with the names of the consumers
meeting the previously noted criteria (Salzer et al., 2007). They were separated by race
and diagnosis to form the following groups: 1) White and schizophrenia spectrum
disorder; 2) African American and schizophrenia spectrum disorder; 3) White and Major
Depression diagnosis; and 4) African American and Major Depression diagnosis. Once
the lists were obtained, chart reviews were completed to verify the diagnosis of each
individual to ensure continued eligibility for the study. The names on each list from the
participating sites were then randomly ordered. The participants were then interviewed
in person by the research team after agency staff had obtained a ‘consent to contact’
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form. Three interviews were completed. The first interview provided baseline
information. The second interview was conducted six months later, and the third
interview was conducted 1 year later after the initial baseline interview. This study used
information from the first interview only.
Analysis of Risk/Benefit Ratio
Potential Risk to Participants
The data for this study came from an already completed research project. All of
the information was de-identified before it was made available for analysis . Therefore,
there was no additional potential for risk to the participants.
Potential Benefit to Participants
There will be no potential benefit to participants in this study, as this is an
archival data set. However, the results of this study will benefit others who have been
diagnosed with a serious mental illness, such that the mental health professionals working
with these individuals will help to enhance empowerment and ultimately perceived
efficacy.
Potential Benefit to Others
This study will serve to improve the current understanding of the relationship of
empowerment on treatment outcomes in an individual with a serious mental illness.
Specifically, it expands on the current definition of empowerment to provide clearer use
of the construct.
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Procedures for Maintaining Confidentiality
As previously noted, this study utilized data from an already completed research
project, and was de-identified for the purposes of running statistical analyses that
heretofore have not been run. Therefore, this study did not risk breaching confidentiality
of the participants in any way.
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Chapter 5: Results
In the current study, three sets of hierarchical regressions were conducted to
examine the following three questions: (a) Does the working alliance and perceived
global empowerment predict patient’s perceived self-efficacy in their interactions with
their psychiatrists?; (b) To what extent does perceived self-efficacy in interactions with
psychiatrists, perceived global empowerment, and the therapeutic or working alliance
predict patients’ perceptions of inclusion in treatment decision making?; and, (c) What is
the relative contribution of the therapeutic alliance, perception of global empowerment,
perceived self-efficacy in interactions with physicians, and inclusion in treatment
decision making to the individuals’ perceived satisfaction with treatment?
In addition to the hierarchical regressions just described and those presented later,
hierarchical regressions were also run with demographics in the first step for each
hypothesis in order to control for potential confounding variables. The demographic
variables included race, gender, diagnosis, socioeconomic status, residential status,
employment status, and education. Race was broken into two categories, Black or White,
aspart of the inclusion criteria of the original data set as previously noted. Gender was
broken into two categories: male or female. Participants’ diagnoses were separated into
two categories in accordance with the original data set: Major Depression or a
schizophrenia-spectrum disorder (including schizophrenia, schizoaffective disorder).
Socioeconomic status was determined by whether the participant received social security
income (e.g., SSI or SSDI). Residential status included the presence of homelessness,
including lifetime experience of homelessness. Employment status measured whether the
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individual was or was not employed at the time of the original data collection. Finally,
participants’ educational status included the following three categories: High School,
Less Than High School, or More Than High School.
Of the total of 396 individuals included in the study, 149 (37.6%) were White,
while 247 (62.4%) were Black. Two hundred thirty three women were involved in the
study (58.84%). In addition, 158 individuals had a confirmed diagnosis of Major
Depression (39.9%) and 238 participants were diagnosed with a schizophrenia-spectrum
disorder (60.1%).
Among the diagnostic breakdown, of the 158 individuals with a diagnosis of
Major Depression, 156 completed the WAI-C-S, 157 completed the ES, 157 completed
the PEPPI, 153 completed the PDMS, and 156 completed the MHSIP. Of the 238
individuals diagnosed with a schizophrenia-spectrum disorder, 232 completed the WAI,
237 completed the ES, 237 completed the PEPPI, 228 completed the PDMS, and 236
completed the MHSIP. A complete listing of all demographic variables is shown in Table
1. The means and standard deviations of the dependent and independent variables are
listed in Table 2.
The results from the additional regressions accounted for only a very small
percentage of the variance in the variables of interest. For this reason, the regressions
with the demographics are not presented in the Results section of this document. The
only demographic that demonstrated some contribution, though insignificant, was the
diagnosis of schizophrenia/schizophrenia-spectrum disorder. The reason for the result is
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unclear; however, because of the importance of developing recovery-oriented care for all
people with SMI, attempts were made to explain the findings in the Discussion section.

Table 1
Demographics of Patient Participants
Characteristic
N
%
Gender
Female
233
58.84
Male
163
41.2
Race/ethnicity
White
149
37.63
Black
247
62.37
a
Education
Less than high school
169
43.56
High school
123
31.70
More than high school
96
24.74
Employmentb
Not currently employed
349
88.35
Currently employed
46
11.65
Diagnosis
Major Depression
158
39.90
Schizophrenia
238
60.10
SSI Incomec
0 (does not receive SSI)
63
15.95
1 (does receive SSI)
332
84.05
Ever Homelessd
Has not been homeless at one
point
205
51.90
Has been homeless at one point
190
48.10
Note. N = 396. SSI= social security income. aMissing
demographic data in the Education category: 8 missing. bMissing
demographic data in the Employment category: 1 missing.
c
Missing demographic data in the SSI Income category: 1
missing. dMissing demographic data in the Ever Homeless
category: 1 missing.
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Table 2
Means and Standard Deviations of Dependent Variables
and Independent Variables
Measures
N
M (SD)
ES
394
2.79 (0.28)
WAI-C-S
388
5.41 (1.17)
PEPPI
394
3.72 (0.90)
PDMS sum
381
7.96 (2.38)
MHSIP sum
392
17.87 (5.58)
Note. ES = Empowerment Scale; WAI-C-S = Working
Alliance Inventory-Client Version, Short Form; PEPPI =
Perceived Efficacy in Patient-Physician Interaction Scale;
PDMS sum = Participatory Decision-Making Scale sum
(sum score); MHSIP sum = Mental Health Statistics
Improvement Program Adult Consumer Survey (sum
score).

Preliminary Analyses
Correlational Matrix
To explain the relationships between one or more predictor variables and one
dependent variable, multiple regression analyses are frequently used. In order to be
deemed valid, regression models rely on the assumptions of linearity, normality, and
multicollinearity. To assess for the presence of multicollinearity of variables, correlation
matrices were run between the independent and dependent variables in this study.
Tabachnick and Fidell (2001) suggested that correlation coefficients of .90 or higher are
considered threats to multicollinearity. The data from correlations in this study revealed
no issues of multicollinearity. The highest correlation coefficient between the WAI-C-S
and PEPPI measures in this study was .558, considered a moderate correlation between
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the constructs of working alliance and perceived efficacy in patient-physician
interactions. The correlational matrix is shown in Table 3.

Table 3
Pearson Correlations Between Empowerment, WAI-C-S, PEPPI, PDMS sum, and
MHSIP sum Scales
ES
WAI-C-S PEPPI
PDMS sum
MHSIP sum
ES
1
WAI
.256 1
PEPPI
.359 .558
1
PDMS sum
.259 .389
.285
1
MHSIP sum -.268 -.442
-.340
-.258
1
Note. ES = Empowerment Scale; WAI-C-S = Working Alliance Inventory-Client
Version; Short Form; PEPPI = Perceived Efficacy in Patient-Physician
Interaction Scale; PDMS sum = Participatory Decision-Making Scale (sum
score); MHSIP sum = Mental Health Statistical Improvement Program Adult
Consumer Survey (sum score).

For Question 1, this study used the ES, the WAI-C-S, and the PEPPI, where the
ES and WAI-C-S were the independent or predictor variables, and the PEPPI was the
dependent variable. For Question 2, this study used the WAI-C-S, PEPPI, ES, and the
PDMS, where the WAI-C-S, PEPPI, and ES were the predictor variables, and the PDMS
was the dependent variable. Finally, for Question 3, this study used the WAI-C-S, ES,
PEPPI, PDMS, and the MHSIP, where the WAI-C-S, ES, PEPPI, and PDMS were
independent variables. The MHSIP was the dependent variable. In the current study,
results demonstrated that these scales have significant reliability. Cronbach’s alphas for
the scales are reported in the previous chapter.
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Testing Assumptions
Tests for normality of residuals and heteroscedasticity were conducted in order to
determine the presence of homoscedasticity and normally distributed regression residuals.
Assumptions were examined in two ways: (a) using a residual predicted scatterplot to
examine for the presence of variance in the spread in residuals for different predicted
values of the dependent variables and (b) using White’s test (1980). White’s (1980) test
was used to examine the functional form of a regression model for potential problems of
heteroscedasticity and misspecification. In this statistical test, the null hypothesis tests
whether the regression model’s specification of the first and second moment of the
dependent variable is correct. Therefore, the null hypothesis then becomes a joint
hypothesis and asserts that the residuals are independent of the exploratory variables and
that the regression model has been correctly specified. In the present study, for all
regressions, residuals were approximately normal, and White’s test showed no significant
heteroscedasticity. Furthermore, the results indicated that there were no substantial
violations of regression assumptions.
Hypothesis 1: PEPPI Hypothesis
To test the hypothesis that higher scores on the ES and the WAI-C-S would be
predictive of higher PEPPI scores, multiple hierarchical regression analyses, performed in
Statistical Analysis Software (SAS), were conducted to determine the relationships.
In the first hierarchical regression, PEPPI was regressed on ES and WAI-C-S. The
Intercept term was also included in this and all succeeding regressions used to test the
hypotheses. In the first step of the hierarchical regression, PEPPI was regressed on
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Empowerment. Data from 384 participants were used; 12 participants failed to complete
the questionnaire thoroughly (N = 384). The model produced an R-square of 0.13, which
was statistically significant, F(2, 383) = 57.06, p < .0001. Empowerment and the
intercept accounted for 13% of the total variance in PEPPI scores. In the second step of
the hierarchical regression, WAI-C-S was entered into the model. The model then
produced an R-square of 0.36, which was also statistically significant, F(2, 383) =
108.99, p < .0001. This result indicated that the WAI-CS alone accounted for
approximately 23% of the total variance in PEPPI. To further evaluate the predictive
nature of the independent variables on the PEPPI, the variables were entered into the
model in reverse order. PEPPI was first regressed on WAI-C-S. The model produced an
R-square of 0.31, which was statistically significant, F(1, 383) = 174.16, p < .0001. The
results indicated that WAI-C-S and the Intercept accounted for 31% of the total variance
in PEPPI scores. ES was then added into the regression model in the second step of the
hierarchical regression, and produced an R-square of 0.36, which was also statistically
significant, F(2, 383) = 108.99, p < .0001]. The results indicated that WAI and ES
accounted for 36% of the total variance in PEPPI scores, though the ES appeared to
account for only 5% of the total variance. Results from the PEPPI hierarchical
regressions are shown in Table 4.
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Table 4
Summary of PEPPI Hierarchical Regression Analyses
Regression 1
Regression 2
Regression 3
Variables
β ± SE
β ± SE
β ± SE
1.39 ± 0.18
Intercept
0.51 ± 0.43
-0.45 ± 0.38
***
Empowerment 1.15 ± 0.15 *** 0.75 ± 0.14 ***
----0.43 ± 0.03
WAI-C-S
----0.39 ± 0.03 ***
***
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Regression 4
β ± SE
-0.45 ± 0.38
0.75 ± 0.14 ***
0.39 ± 0.03 ***

F-statistic
57.06 ***
108.99 ***
174.16 ***
108.99 ***
R-squared
0.13
0.36
0.31
0.36
Note. N = 396; n = 384; missing data from 21 participants. PEPPI = Perceived
Efficacy in Patient-Physician Interaction Scale; SE = standard error; WAI-C-S =
Working Alliance Inventory-Client Version, Short Form. *p < 0.05. **p < 0.01. ***p
< 0.001.

Hypothesis 2: PDMS Hypothesis
To test the hypothesis that higher scores on the WAI-C-S, ES, and PEPPI would
be predictive of the higher PDMS scores, multiple hierarchical regression analyses were
again conducted to evaluate the relationship between the predictor variables of WAI-C-S,
ES, and PEPPI with the criterion variable PDMS. Two hierarchical regression models
were run, also using SAS.
In the first hierarchical regression, PDMS was regressed on ES, PEPPI, and WAIC-S. Data from 374 participants were used; data from 22 participants were missing. In
the first step of the regression, PDMS was regressed on ES and PEPPI. The model
produced an R-square of 0.11, which was statistically significant, F(2, 374) = 21.92, p <
.0001. The results from the model indicated that ES and PEPPI accounted for 11% of the
total variance in PDMS scores. Empowerment was positively correlated to PDMS (β =
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16.4, t = 3.34, p = .0009). PEPPI was also positively correlated to PDMS (β = 6.26, t =
4.08, p < .0001). In the second step of the hierarchical regression, the predictor variable
WAI-C-S was entered into the model. This model produced an R-square of 0.18, which
was also statistically significant, F(3, 374) = 25.96, p < .0001. ES and WAI-C-S
accounted for 18% of the total variance in PDMS scores. Empowerment remained
positively correlated to PDMS scores (β = 14.24, t = 3.01, p < .003). WAI-C-S was also
positively correlated to PDMS (β = 7.23, t = 5.53, p < .0001). PEPPI did not enter the
model.
A second hierarchical regression was conducted, and the predictor variables were
entered in reverse order to better understand the predictive nature of the variables on the
criterion variable PDMS. Data from 374 participants were used to test the model; data
from 22 participants were missing. In the first step of the second regression, PDMS was
regressed on ES and WAI-C-S. The model produced an R-square of 0.173, which was
statistically significant, F(2, 374) = 38.77, p < .0001]. ES and WAI-C-S accounted for
17.3% of the total variance in PDMS. ES was positively correlated to PDMS (β = 15.11,
t = 3.31, p < .0001). WAI-C-S was also positively correlated to PDMS (β = 7.7, t = 6.94,
p = .001). In the second step of the hierarchical regression, PEPPI was entered into the
model. This model produced an R-square of 0.174, which was statistically significant,
F(3, 374) = 25.96, p < .0001]. Results indicated that PEPPI contributed only
approximately 0.1% to the total variance in PDMS scores. ES was positively correlated to
PDMS (β = 14.24, t = 3.01, p = .003). WAI-C-S was also positively correlated to PDMS
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(β = 7.23, t = 5.53, p < .0001). PEPPI did not enter the model. Results from the PDMS
hierarchical regressions are shown in Table 5.

Table 5
Summary of PDMS Hierarchical Regression Analyses
Regression 1
Regression 2
Regression 3
Variables
β ± SE
β ± SE
β ± SE
-28.13 ±
Intercept
-13.9 ± 12.8
-28.71 ± 12.6*
12.63*
Empowerment 16.4 ± 4.9 *** 14.24 ± 4.74** 15.11 ± 4.56**
WAI-C-S

-----

7.23 ± 1.31***

7.7 ± 1.11 ***

Regression 4
β ± SE
-28.13 ±
12.63*
14.24 ± 4.74**
7.23 ± 1.31***

6.25 ± 1.53***
1.19 ± 1.73
----1.19 ± 1.73
PEPPI
F-statistic
21.92 ***
25.96***
38.77***
25.96***
R-squared
0.11
0.18
0.173
0.174
Note. N = 396; n = 375; missing data from 21 participants. PDMS sum =
Participatory Decision-Making Scale (sum score); SE = standard error; WAI-C-S =
Working Alliance Inventory-Client Version, Short Form; PEPPI = Perceived Efficacy
in Patient-Physician Interaction Scale;. *p < 0.05. **p < 0.01. ***p < 0.001.

Hypothesis 3: MHSIP Hypothesis
To test the hypothesis that higher WAI-C-S, ES, PEPPI, and PDMS would be
predictive of greater overall satisfaction in treatment as measured by the MHSIP,
multiple hierarchical regression analyses were conducted, performed in SAS, to
determine the relationships between the criterion variable MHSIP and the following
predictor variables: working alliance, empowerment, perceived self-efficacy in patientphysician interactions, and inclusion in treatment decision making. Two hierarchical
regression analyses were conducted to determine the relative contribution of each of the
predictor variables to the criterion variable.
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In the first hierarchical regression, MHSIP was regressed on ES, WAI-C-S,
PEPPI, and PDMS. Data from 374 participants were used to determine the contribution
of the variables to the total variance in MHSIP; data from 21 participants were missing.
In the first step of the regression, MHSIP was regressed on ES and PDMS. This model
produced an R-square of 0.11, which was statistically significant, F(2, 374) = 23.75, p <
.0001. The ES and PDMS accounted for 11% of the total variance in MHSIP. ES was
negatively correlated to MHSIP (β = -4.37, t = -4.39, p < .0001). PDMS was also
negatively correlated to MHSIP (β = -.04, t = -4.01, p < .0001). In the second step of the
regression, MHSIP was regressed on ES, PDMS, and PEPPI. This model produced an Rsquare of 0.16, which was statistically significant, F(3, 374) = 23.16, p < .0001. ES,
PDMS, and PEPPI accounted for approximately 16% of the total variance in MHSIP
scores, and PEPPI contributed approximately 5% of the total variance of MHSIP. ES
was negatively correlated to MHSIP (β = -2.92, t = -2.85, p = .005). PDMS was also
negatively correlated to MHSIP (β = -0.03, t = -3.10, p = .002). PEPPI was also
negatively correlated to MHSIP (β = -1.42, t = -4.43, p < .0001). In the third step of the
regression, WAI-C-S was entered into the model. The model produced an R-square of
0.23, which was statistically significant, F(4, 374) = 27.59, p < .0001. ES and WAI-C-S
accounted for 23% of the total variance in MHSIP scores, and WAI-C-S contributed
approximately 7% of the total variance in MHSIP. ES was negatively correlated to
MHSIP (β = -2.71, t = -2.77, p = .006). WAI-C-S was also negatively correlated to
MHSIP (β = -1.64, t = -5.88, p < .0001). PDMS and PEPPI did not enter the model.
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In order to better understand the contributions of the predictor variables to the
criterion variable, the independent variables WAI-C-S and PEPPI were entered into the
model in reverse order. The first step of the hierarchical regression was the same as in
the first hierarchical regression of this model. In the second step of the regression,
MHSIP was regressed on ES, PDMS, and WAI-C-S. This model produced an R-square
of 0.23, which was statistically significant, F(3, 374) = 36.38, p < .0001. ES and WAI-CS accounted for 23% of the total variance in MHSIP. ES was negatively related to
MHSIP (β = -2.99, t = -3.16, p = .002). WAI-C-S was also negatively related to MHSIP
(β = -1.79, t = -7.40, p < .0001). PDMS did not enter the model when WAI-C-S was
entered. In the third step of the regression, MHSIP was regressed on ES, PDMS, WAI-CS, and PEPPI. This model produced an R-square of 0.23, which was statistically
significant, F(4, 374) = 27.59, p < .0001. ES and WAI-C-S accounted for 23% of the
total variance in MHSIP scores. ES was negatively related to MHSIP (β = -2.71, t = 2.77, p = .006). WAI-C-S was also negatively related to MHSIP (β = -1.64, t = -5.88, p <
.0001). PDMS and PEPPI did not enter the model. Results from the MHSIP hierarchical
regressions 1 – 4 are shown in Table 6. Results from the MHSIP hierarchical regression
5 is shown in Table 7.
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Table 6
Summary of MHSIP Hierarchical Analyses 1 – 4 (n = 374)
Regression 3
Regression 1
Regression 2
β ± SE
Variables
β ± SE
β ± SE
32.47 ±
33.17 ±
36.64 ±
Intercept
2.71***
2.65***
2.60***
Empowerment
-4.37 ± 0.99*** -2.92 ± 1.02** -2.71 ±0.98**
-1.64 ±
WAI-C-S
--------0.28***
-1.42 ± 0.32
PEPPI
----***
-0.39 ± 0.36
-0.04 ± 0.01
PDMS sum
***
-0.03 ± 0.01**
-0.02 ± 0.01
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Regression 4
β ± SE
36.82 ± 2.60***
-2.99 ± 0.95*
-1.79 ± 0.24
***
-----0.02 ± 0.01

F-statistic
23.75***
23.16***
27.59***
36.38***
R-squared
0.11
0.16
0.23
0.230.11
Note. Missing data from 21 participants. MHSIP = Mental Health Statistics
Improvement Program Adult Consumer Survey; SE = standard error; WAI-C-S =
Working Alliance Inventory-Client Version, Short Form; PEPPI = Perceived Efficacy in
Patient-Physician Interaction Scale; PDMS sum = Participatory Decision-Making Scale
(sum score). *p < .05; **p < .01; ***p < .001.

Table 7
Summary of MHSIP, 5th Hierarchical Analysis (n = 374)
Regression 5
Variables
β ± SE
Intercept
36.64 ± 2.60***
Empowerment
-2.71 ±0.98**
WAI-C-S
-1.64 ± 0.28***
PEPPI
-0.39 ± 0.35
PDMS sum
-0.02 ± 0.01
F-statistic
27.59***
R-squared
0.23
Note. Missing data from 21 participants. MHSIP = Mental Health Statistics
Improvement Program Adult Consumer Survey; WAI-C-S = Working Alliance
Inventory-Client Version, Short Form; PEPPI = Perceived Efficacy in Patient-Physician
Interaction Scale; PDMS sum = Participatory Decision-Making Scale (sum score). *p <
.05; **p < .01; ***p < .001
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Chapter 6: Discussion
The objective of the study was to uncover the relationships between consumerreported levels of empowerment and working alliance with their reported perceived selfefficacy, inclusion in treatment decision making, and treatment outcomes for the purpose
of providing guidance to provider training and program direction. This study also sought
to further the current literature and understanding of the nature and value of assisting
consumers of behavioral-health services to actively engage in their behavioral-health
treatment. To study the relationships between the constructs, multiple hierarchical
regressions were used in order to determine which of several independent variables were
predictive of the dependent variable. The analyses were conducted in three stages, using
two regression models for each hypothesis. In each stage, a part of the prediction model
was tested using both predictor and criterion variables. In the first hypothesis, the
relationship among overall global empowerment, therapeutic alliance, and treatmentspecific efficacy was examined. The second hypothesis focused on the relative
contribution of global empowerment, therapeutic alliance, and treatment-specific efficacy
on the sense of inclusion in treatment decision making. In the final hypothesis, all of the
previously mentioned process and internal variables were examined to determine their
relationship with perceived mental-health treatment outcomes. The following discussion
will review the results that were obtained in this study.
Study Findings
The study found that higher therapeutic alliance and perceived global
empowerment were significant predictors of greater perceived self-efficacy in
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interactions with physicians/clinicians. Additionally, it found that having a diagnosis of
depression versus schizophrenia was a significant predictor of perceived treatmentspecific self-efficacy. These results suggest when individuals with SMI, specifically
those diagnosed with depression, are able to develop a greater sense of rapport within the
therapeutic relationship and simultaneously embody a greater sense of overall
empowerment, these individuals are more likely to feel more efficacious in asking
treatment-related questions in their interactions with their physicians. This finding is
important to the field because of the growing body of literature that indicates that
knowledge of options and choices for treatment yields greater positive treatment
outcomes (Reavley & Jorm, 2011).
One potential explanation for the greater self-efficacy in individuals with
depression versus schizophrenia may be related to issues of ability to form helpful and
well-bonded relationships with others. Barriers may, in fact, be related to the experience
of specific symptoms related to a diagnosis of schizophrenia, including the positive and
negative symptoms of the diagnosis. For example, an individual experiencing auditory
hallucinations commenting in a derogatory manner about themselves and others in their
social environment may then begin to experience a pervasive belief that others are not
able to be trusted. As a result, they may believe that others want to bring them harm,
shame, or other aversive emotions or experiences. When put in the context of attachment
theory, which proposes a developmental model of psychological functioning and emotion
regulation that develops from affectional bonds with close others in the environment of
care, the experience of symptoms of psychosis becomes the negative life event (e.g.,
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trauma) that prevents the individual from attaching securely to contemporaries as adults
(Bowlby, 1980; Weinfield, Whaley, & Egeland, 2004). Analogue samples have
demonstrated a correlation between self-reported attachment avoidance and paranoia
(MacBeth, Schwannauer, & Gumley, 2008; Pickering, Simpson, & Bentall, 2008).
Studies have also demonstrated a relationship between attachment anxiety, attachment
avoidance, and hallucinations (MacBeth et al., 2008). Thus, if having a diagnosis of SMI
and the psychological and experiential sequellae that develop from symptoms of
psychosis, the likelihood of developing a lasting bond with anyone is very poor, until that
individual is able to experience a relief in their symptoms and is able to rebuild
relationships with trusted others.
Additionally, when considering the pervasive experience of stigma related to a
diagnosis of schizophrenia, the fact that individuals with schizophrenia tend to experience
higher levels of stigma may result in lower self-efficacy in relation to their ability to
recover. In other words, the negative impact of stigma on sense of ability to enact change
is greater in individuals who are diagnosed with schizophrenia than with depression. In a
study by Kleim et al. (2008), individuals with schizophrenia self-reported experiences of
stigma as the primary barrier to recovery in schizophrenia, “over and above the amount
of variance in recovery explained by positive and negative symptoms, depression, insight
into illness, age, and gender” (p. 486). These findings demonstrated the negative
influence of stigma on perception of self-efficacy in individuals diagnosed with mental
illness. Further research is needed to determine why there is a differential relationship by
diagnosis with treatment-specific self-efficacy. The results from the current study
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highlight that clinicians should be aware that their patients may have different levels of
self-efficacy given their diagnosis and other possible predictors not tested in the current
model. Self-efficacy ought to be addressed and explored in the context of the therapeutic
relationship to ensure that each individual is able to develop treatment specific selfefficacy.
The second set of analyses found that greater reported perceived therapeutic
alliance and global empowerment were significant predictors of individuals’ perceptions
of inclusion in treatment decision making, as was hypothesized; however, self-efficacy
was not predictive in this model. These results indicate that individuals who tend to feel
more empowered in their lives may also already be predisposed to the ability to develop
working relationships with their providers, as well as advocate for themselves in the
patient-physician relationship. If empowerment is conceptualized as a trait characteristic,
then individuals who embody higher levels of empowerment may be more likely to
actively engage with their physicians. Active engagement in the relationship, in turn,
may result in their physicians using a more inclusive approach in order to maintain the
rapport with the more empowered patient.
Trait characteristics can be further understood by considering locus of control
theory, expanded upon by Sue’s (1978) discussion that the ability to enact change in
one’s life circumstances is related to the interaction between internal experiences, such as
beliefs in one’s ability to enact change, and the greater social world (see also Cattaneo &
Chapman, 2010). According to Sue & Sue (2007), perceived locus of control is
powerfully impacted upon by experienced social forces in a person’s social world and by
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the individual’s ability to both obtain and exercise power (as cited in Cattaneo &
Chapman, 2010). Social forces may include the presence of powerful others and
regulatory agencies or institutions that regulate behavior and can be seen as the reason
that groups with less social power tend to report experiencing a more external locus of
control (Sue & Sue, 2007). Thus, empowerment also can be viewed as an indication of
positive adaptation to treatment and resilience among individuals with schizophrenia
when interacting with their physicians. Further research should be conducted to
determine other factors that correlate with greater levels of empowerment in individuals
diagnosed with SMI.
The positive correlation found in this study between working alliance and
participatory decision making is not surprising given that shared decision making
communicates interest in the patient’s needs and wants and is less directive in nature.
Showing interest and concern and having good listening skills are all variables related to
developing a positive working alliance. However, further research should be conducted to
better understand the most effective ways of increasing a physician’s ability to develop
the therapeutic relationship with consumers with SMI given the observed correlation
among empowerment, alliance, and the physician’s use of a shared decision-making
style.
Of note, PEPPI did not reach statistical significance in both of the regression
models that were conducted on the PDMS hypothesis, indicating that perceived selfefficacy in interactions with a treating physician is not a significant predictor of
perception of inclusion in treatment decision making. This finding contradicts previous
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research findings and is interesting because the correlational matrix demonstrated only a
moderate correlation between the two variables. PEPPI’s lack of significance could have
been obtained for several reasons. After the other independent variables were included in
the regression model, treatment-specific efficacy most likely no longer had a significant
relationship with the dependent variable PDMS. Therapeutic relationship and perceived
efficacy in interactions with physicians are conceptually related. Perhaps the items on the
WAI-C-S and the PEPPI were too similar in nature. In other words, any variance in
PDMS that could have been measured by PEPPI is being explained or accounted for by
the WAI-C-S because of the moderate correlation found in the correlation matrix between
PEPPI and WAI. Therefore, the moderate inter-correlation between PEPPI and WAI-C-S
is the most plausible explanation for the nonfindings of the PEPPI in the regression
model.
A second reason that PEPPI may not have been significant may be because PEPPI
is not an accurate representation of an individual’s ability to interact with his or her
mental-health clinician. When considering that beliefs of self-efficacy affect how
individuals think, feel, behave, and motivate themselves, this task-/context-specific
variable may not be significant. As has been suggested, having high self-efficacy does
not compel an individual to enact change (Smits & Bosscher, 1998). In other words, one
can experience a high sense of control in one’s life but not always feel able to speak up
about treatment needs when interacting with treatment providers in everyday situations.
However, if individuals have a strong working alliance with their physicians/clinicians,
they more likely will feel they are able to speak up for their needs and perceive that their
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physicians are more inclusive in the treatment decision making. Additionally, one can
have high self-efficacy, though not perceive that the provider engages in a shared
decision-making style, making self-efficacy it less likely to be perceived as related to
PDMS. In other words, the treating clinician may not have been using a PDM style, and
this lack of inclusion is being reflected in the results.
Results from the final hypothesis regarding treatment outcomes indicated that
satisfaction with treatment outcomes is strongly correlated to individuals’ perceptions of
the working alliance, sense of overall empowerment, and perception of inclusion in
treatment decision making with their treating clinicians. The correlation found between
the therapeutic alliance and treatment outcomes in this hypothesis is not surprising when
considering the constructs measured in the working alliance. Recall that the measure
examines the degree to which the client and therapist bond, the degree to which the client
and therapist collaborate on specific therapeutic activities or tasks, and the degree to
which the client and therapist agree on the global objectives or goals of the therapy
(Horvath & Greenberg, 1989). With the focus of the measure on the bond, the goals, and
the tasks in the therapeutic interactions, logic permits that individuals who feel closer to
their therapist would also feel that their therapists include them in treatment decisions.
Furthermore, these individuals likely are going to report greater outcomes in their
treatment. Research studies have demonstrated good evidence to support assertions that
the quality of the therapeutic alliance is predictive of the therapeutic outcome (Horvath &
Greenberg, 1989; Marmarosh et al., 2009).
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Satisfaction was also diagnosis dependent, with individuals diagnosed with major
depression reporting satisfaction with treatment greater than that reported by individuals
diagnosed with schizophrenia. Additionally, this analysis found that satisfaction with
treatment outcomes was not significantly related to the overall perception of self-efficacy
in patient-physician interactions. The latter results, similar to those of the preceding
hypothesis, also contradict previous research findings that treatment- specific selfefficacy plays an important predictive role in an individual’s overall treatment gains and
recovery (Maly et al., 1989). These nonfindings in PEPPI significance are likely related
to the previously listed reasons. Additionally, the result may be influenced by the fact that
items in the PEPPI are related to a medical setting. According to the developers of the
scale, PEPPI is designed to determine the amount of perceived self-efficacy when
interacting with physicians during medical appointments (Maly et al., 1998). Possibly,
the PEPPI is not an appropriate measure to use outside of the medical setting, and
attempts to use PEPPI to demonstrate predictive value in mental-health treatment
outcomes is an inappropriate use of the scale. Further research should be conducted to
determine the validity of using the PEPPI in mental-health research. In addition, future
research should also focus on developing a scale that is more specifically related to
treatment-specific self-efficacy in the mental-health field.
Results also indicated that individuals diagnosed with depression rated their
satisfaction with their treatment outcomes greater as compared to that rated by
individuals diagnosed with a schizophrenia-spectrum disorder. These results are not
easily interpretable. First, the results may have been obtained because individuals with
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depression might have been able to achieve greater duration of relief from symptoms or a
reduction in other psychosocial stressors associated with the diagnosis. The literature
indicates that 60-80% of individuals diagnosed with depression are able to find
significant recovery from their symptoms when remaining adherent to treatment
regimens, including medications and psychotherapy (Smits & Bosscher, 1998). However,
the literature also indicates that individuals diagnosed with depression experience a high
rate of relapse, noting that 60 to 80% of individuals who recover do experience a relapse
within 5 to 10 years (Lee & Murray, 1988; Keller, Lavori, Mueller, Endicott, et al., 1992;
Kiloh, Andrews, & Neilson, 1988; Surtees & Barkley, 1994). In this study, participants
with schizophrenia may not have experienced a decrease in symptoms. Additionally,
study participants may have had a generally higher subjective acuity of symptoms and/or
a possible increase in their experience of symptoms at the time of data collection. As was
reviewed in a prior section, lower acuity in symptom presentation, as measured by the
Positive and Negative Symptom Scale (PANSS), has been associated with stronger
therapeutic alliance and greater treatment outcomes (Frank & Gunderson, 1987; Kay,
Fiszbein, & Opler, 1987). However, the association should be considered with caution,
as the findings on the relationship between symptom severity and treatment outcomes are
somewhat mixed. In addition, treatment outcomes may be less favorably perceived by
individuals with schizophrenia because of similar reasons related to stigma, as previously
noted. Future research should focus on the impact that symptom severity and ability or
skill in forming adult attachments has on treatment outcomes in individuals with
schizophrenia spectrum and major depressive disorders. Perhaps, as individuals
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experience a remission in their symptoms over time, their perceived satisfaction in
treatment increases. Likewise, future research on this focus may demonstrate that as an
individual gains the skills needed to develop relationships, his or her ability to engage in
the treatment improves, thus leading to better treatment outcomes.
Potential Limitations
Some limitations exist in this study. First, the relationships that were found to
exist among the variables cannot be considered to be causal. The present study is based
on a cross-sectional design and prevents the drawing of causal relationships. Concerning
the PDMS and MHSIP hypotheses, attention must be drawn to the fact that this study did
not differentiate between respondents referring to either clinicians or physicians when
completing the measures. Instead, eligible participants were instructed to answer items
on the PDMS and MHSIP scales using their overall impression of experiences with either
their therapists or their psychiatrists. Therefore, the information that was obtained in the
analyses cannot and should not be considered representational of either category of
mental-health professional, but instead of the combination of the two mental-health
professionals. Therefore, the results, while significant, cannot be easily generalized to
one specific population of treatment providers, because nonmedically trained clinicians
may embody characteristics different from those of their medically-trained counterparts
related to their training (e.g., patient-centered versus the medical model/physiciandirected approaches to treatment). Furthermore, participant age was another variable that
was not controlled for in this study. Considering that one study found that age in
individuals with SMI is correlated to positive treatment outcomes (see Solomon et al.,
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1995), the lack of inclusion of this variable in the model for the third hypothesis may
have left the model underspecified.
Finally, the self-report nature of the data that were used has some limitations.
Confidence in self-report data is limited by a variety of possible biases, and though
attempts were made to control for the social desirability bias in the procedures of this
study, participants may have overreported or underreported the presence or lack of items
on each of the measures used in the study data. Furthermore, participants’ self-reports
may have been subject to recall bias as they attempted to respond to questions about
current treatment. Regardless of the noted limitations to this study, the results suggest
significant correlations between sense of overall empowerment, working alliance,
perceived treatment-specific self-efficacy, and inclusion in treatment decision making in
perceived behavioral health treatment outcomes.
Future Directions
Training for present and future clinicians has primarily focused on the theoretical
aspects and approaches to treatment for individuals not diagnosed with SMI, though
training is slowly changing. The guidelines for transformation in the behavioral-health
system have been integral in changing the landscape of treatment for individuals with
SMI. Several qualitative studies have pointed out that individuals with SMI need
supportive, hopeful, respectful provider relationships and must feel that they are being
heard. Research demonstrates that attempting to provide treatment interventions prior to
the development of a strong therapeutic relationship is likely to yield frustration on the
part of both the patient and the clinician, regardless of the presence or absence of SMI.
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The results from this study suggest that future research should focus on development of
training for clinicians who provide treatment to individuals with SMI. Specifically, the
training should include the development of intervention skills necessary to build rapport
and a strong therapeutic alliance with these individuals. Interventions should also focus
on increasing individuals’ sense of overall empowerment, as the results from this study
suggest that empowerment is a necessary part of recovery from mental illness.
If global empowerment adds to the sense of inclusion in treatment decisionmaking and satisfaction in treatment outcomes, then treatment providers have a
responsibility to seek to increase empowerment in individuals with SMI. One helpful
way to empower these individuals is summed up by the concept of mental health-literacy,
which includes the ability to recognize a specific mental illness and understand the
available treatment for a diagnosed disorder (Reavley & Jorm, 2011). Researchers in
mental-health literacy suggest that lack of information about one’s specific disorder (e.g.,
lack of knowledge, risk factors, causes, available treatment options, etc.) significantly
reduces help-seeking behaviors (Jorm, Korten, Jacomb, Rodgers, & Pollitt, 1997;
Reavley & Jorm, 2011). In general, before a problem can be addressed, a person must
first recognize the presence of the problem before seeking help. Recognition requires, at
a minimum, a basic foundation of mental-health literacy for individuals seeking to
recover from their mental illness. Additionally, assisting individuals with identifying and
developing personally meaningful goals can increase that individual’s sense of being
personally invested in his or her treatment.
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Other interventions that can increase empowerment include specific treatment
protocols for clinicians/physicians providing the treatment. Several theoretical models
currently support and enhance understanding of the importance of relationship building in
order to assist individuals to prepare to make necessary changes. These include thirdwave theoretical models of treatment, such as Acceptance and Commitment Therapy
(ACT) and Dialectical Behavior Therapy (DBT), which focus on increasing an
individual’s cognitive flexibility, gaining awareness of his or her expressed values, and
developing behavioral interventions that will allow movement in the direction of his or
her expressed goals (see Hayes, 2004; Linehan, 1993). Additionally, significant research
has been conducted on the Transtheoretical Model of Change, and the Stages of Change
Theory, two important avenues toward meeting individuals where they are in their
readiness for change (Prochaska & DiClemente, 1984; Rollnick & Miller, 1995). Yet
another model for treatment with a side effect of empowerment is assisting individuals
with clarifying their values and then working in collaboration with them to connect them
to community groups that are in line with their expressed values.
Training should also focus on the important role that empowerment plays in
individuals’ abilities to have positive gains in their treatment. Programs should focus on
implementing practical training on improving clinicians’ ability to empower the
consumers for whom they are providing treatment. For example, one leading researcher
on empowerment and SMI suggests, some strategies that serve to enhance the treatment
partnerships (Corrigan et al., 2010). These include (a) using language that endorses
recovery rather than promoting the idea of poor prognoses, (b) developing treatment
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plans that utilize a collaborative and shared decision making approach, rather than
unilateral decision making that is perceived as coercive, and (c) providing effective
treatment services in the person's community rather than at distant establishments
(Corrigan et al., 2010). These strategies are simple at face value. However, they remain
central to the necessary transformation of the behavioral healthcare system. Making
changes in this manner requires each practitioner to fully understand and embrace the
idea that all individuals can recover.
Interestingly, treatment approaches that focus only on the person and the
treatment relationship are not sufficient (Corrigan et al., 2010). Stigma and discrimination
remain significant barriers to the kind of community opportunities that are necessary to
help people attain life goals. Therefore, communities that substitute stigmatizing attitudes
and discriminatory behaviors with realistic views of psychiatric disability are more likely
to provide the kind of reasonable accommodations that some people need for work and
independent living opportunities. This information can guide treatment providers in
making purposeful attempts to advocate for inclusion and integration of individuals with
SMI in the greater community, as community acceptance and integration play a vital part
in recovery. In addition, further research should be conducted to determine the predictors
of empowerment, as this construct, along with the therapeutic alliance, demonstrated the
most consistent significant relationship with all of the criterion variables, specifically the
perceived treatment outcomes.
The findings of the relationship between the empowerment measure and sense of
self-efficacy in patient-physician interactions are important to the field of psychology
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because they suggest people may feel empowered in their overall life, but not necessarily
have the same sense of power and mastery in a very specific context when they are
expected to interact with their physicians. A lack of treatment-specific self-efficacy may
be related to the fact that there is already a power differential that already exists between
the physician and the consumer. Furthermore, individuals who are already globally
empowered may also lack the specific skills needed to ask their physicians questions.
Self-efficacy requires knowledge and the skills to act on this knowledge, and treatment
providers need to improve their efforts in providing consumers with information about
medications, empirically based treatment options, and diagnosis, and, in general, in
demystifying the entire process of treatment. However, one should note that had WAI-CS not been measured in this study, self-efficacy may have been statistically significant in
the results. The constructs measured by the WAI-C-S and PEPPI most likely are similar
enough in nature for this overlap in constructs to result in the PEPPI losing statistical
significance. Future studies should be conducted in order to determine how to best
increase a person’s sense of self-efficacy in interactions with his or her
physicians/treating clinicians. Specifically, one design of a future study could include
individuals who identify having greater knowledge about mental illness, diagnosis,
medications, assertiveness training, etc. Results from a study design such as this could
determine if these individuals would then report greater confidence in their abilities to
interact with their physicians.
Part of the training of new clinicians must include instruction on developing a
strong therapeutic alliance while maintaining other core concepts related to the provision
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of mental-health treatment, such as the theoretical or procedural aspects of training that
are currently the focus of training programs. To date, a number of professional
associations have sought to educate those in the mental-health delivery system about
adopting a more recovery-oriented approach to the treatment of individuals with SMI.
All have been formed/are forming as a direct result of the New Freedom Commission’s
(2003a/b) mandated transformation of the mental health treatment delivery system. For
example, SAMHSA, a division of the United States Department of Health and Human
Services, has developed the Recovery To Practice Initiative, which has awarded grants to
the American Psychiatric Association, the American Psychological Association, the
National Association of Peer Specialists, the Council on Social Work Education, and the
American Psychiatric Nurses Association to develop, pilot-test, and distribute training
materials for practitioners about recovery and SMI (2009). These educational and
training materials are currently being developed by each professional group and are
expected to be ready for dissemination within the next several years. Other initiatives
have been in place for some time and have been integral in the forward movement of the
recovery-oriented approach (see Tondora & Davidson, 2006).
Results from this study also indicated that the tendency for physicians to engage
in a PDM style was significantly correlated with the subjects’ self-reported experiences
of the working alliance and their own sense of empowerment, as well as with greater
reported treatment outcomes. The results suggest that clinicians should receive further
training on better understanding the needs of their patients, particularly the ability to
accurately reflect and act on their patients’ reported needs, in order to develop greater
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inclusion in the treatment process. A discussion of shared decision making regarding
treatment should also consider the limitations of this approach. For example, patients who
present as a danger to themselves and others as the result of an impaired mental status,
thus impairing their ability to care for themselves, do benefit from the temporary partial
removal of right to autonomy, and this decision may indeed be the responsibility of the
clinician under current laws (see O’Connell, 2011). In other words, patients who report
suicidal or homicidal ideation with a plan and intent, patients who are experiencing
significant symptom-related difficulty managing impulses, or patients who are not able to
care for themselves because of the presence of acute symptomatology are less likely to be
able to make treatment decisions that will be beneficial. Physicians and clinicians should
be trained in screening for the presence of problematic symptom presentations and in
assessing the level of mental-health literacy individuals have about what is needed in
order to progress in their recovery. Additionally, physicians and clinicians could benefit
from further training in seeking consultation from the appropriate mental-health
professionals to counter this potential barrier to inclusion in treatment decision making.
The benefit to inclusion in treatment decision making, as already discussed, is
greater perceived treatment outcomes. Future research needs to be conducted into the role
of treatment decision making on treatment gains, adherence, and engagement, and on
other indicators of subjective and objective functioning. Being included in the decisionmaking process regarding one’s treatment is also indicative of a more person-centered
approach to treatment that hopefully will result in higher treatment participation and
objective treatment outcome indicators.
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Conclusion
Overall sense of empowerment, the development of a strong working alliance,
perceived self-efficacy in interactions with treating clinicians, and perception of inclusion
in treatment decision making are all constructs that are considered essential to the
provision of effective treatment of individuals diagnosed with mental illness. This study
sought to determine the relationship among these variables and their abilities to predict
greater satisfaction with treatment outcomes for the purpose of furthering the field’s
understanding of how to best shape the provision of services to individuals with SMI.
Nearly all of the constructs demonstrated significance, with the working alliance,
empowerment, and the perception of inclusion in treatment decision making predicting
overall satisfaction with treatment outcomes. Based on this study, future research should
focus on the development and evaluation of training programs for the clinicians who will
be providing mental-health treatment to these individuals. To help shape these programs,
the behavioral-health services delivery system would benefit from new training modules
for clinicians that will ultimately serve to enhance overall recovery for individuals with
SMI as they build upon their satisfaction with treatment outcomes.
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